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CHAPTER I
INTRODUCTION:

An adequate supply of iron is essential for good health. Iron is required for many
enzymes that are critical for cellular metabolism, and plays a fundamental role in
oxygen carrying proteins such as hemoglobin and myoglobin. Iron also facilitates
oxygen use and storage in muscle, interacts with cytochromes in cellular metabolism,
and serves as cofactor for several tissue enzymes (Yip et al. 1998). Iron can also be
toxic if present in excess as it is able to catalyze the formation of reactive oxygen
species. Because of this dual nature, iron must be kept within defined limits and there
are precise mechanism governing the regulation of the iron homeostasis.

Iron is present in the diet as one of the two forms: as inorganic (non-heme) iron or
heme iron. Of these, inorganic iron is the predominant form of iron in dietary
components of plant origin and accounts for 80-90% dietary iron (Hallberg, 1981;
Carpenter and Mahoney 1992), with the remaining 10% as heme iron. The inorganic
form of iron is poorly absorbed in the body because of its low solubility and hence it
is desirable to make inorganic iron more potentially bioavailable (Berner and Miller,
1985). Extensive research has been done in last five decades to determine the
components which can make the dietary iron more potentially bioavailable. A number
of such identified carriers are ascorbic acid, amino acids and peptides.

Researchers have focused on several dietary components for their iron enhancing or
inhibiting effect. Many plant components such as phytate, polyphenols (Gilloly et al.
1983) and soy protein (Cook et al. 1981) inhibit, whereas some animal tissues (Cook
1

et al. 1975, Hurrel et al. 1988) enhance non-heme iron absorption in humans. The
enhancing effect of meat is attributed to unknown factors, usually referred as ‘meat
factor’. Meat tissue may also maintain the iron in soluble form, thereby increasing its
bioavailability (Carpenter and Mahoney, 1992). Not all the animal proteins have
enhancing effect on iron bioavailability. For example, beef, lamb, liver, pork, poultry
and fish enhance non-heme iron absorption, but egg, cheese and milk do not (Layrisse
et al. 1969; Cook et al. 1976; Rasmussen and Hallberg 1979).

However, not much attention has been given to what extent food preparation, such as
cooking, affects the non-heme iron bioavailability. Cysteine containing peptides of
meat, e.g. glutathione (Taylor et al. 1986) and sulfhydryl (-SH) and (disulphide
groups) in meat (Hoffman and Hamm 1978), have been suggested to be responsible
for ‘meat factor’, but the effect of cooking on these factors has not been given much
consideration even though it is well known that sulfhydryls are heat labile (Taylor et
al 1986). Baech et al. studied the effect of increasing cooking temperature on meat
and concluded that increasing cooking temperature does not affect the non-heme iron
absorption from a phytate rich meal (Baech et al. 2002). But the reference point in this
study was meat cooked at 70oC and not raw meat and also the meal was phytate rich.

Based on the literature review the objective of the present study is to investigate the
effect of increasing cooking temperature of chicken muscle on in-vitro measure of
non-heme iron bioavailability. The specific objectives are

2

 To study the effect of cooking temperature on production of potentially
bioavailable iron species resulting from in-vitro pepsin and pancreatin
digestion.
 To study the effect of cooking temperature on critical amino acids, such as,
sulfhydryl and histidine content of chicken muscle.

3

CHAPTER II
LITERATURE REVIEW:
II.A Iron:

Iron is placed in 8th group and 4th period in periodic table and has atomic weight of
55.845. Iron is a relatively abundant element on earth and is the fourth most common
metal on earth. Iron catalyzes great number of biochemical reactions, many of which
are related to the chemical nature of the element characterized by two principle
oxidation states: divalent iron (Fe II (d-6)) and trivalent (Fe III (d-5)) and their
associated ability to form complexes.

II.B The history of Iron:

The relation of iron to blood formation did not become apparent until the seventh
century when two English physicians, Sydenham and Willis, found simple salts of
iron to be of value in treatment of chlorosis in women. This relationship was placed
on more rational basis by the discovery that iron is a characteristic constituent of
blood. After this Lecanu had shown that hemoglobin contains iron, and, in 1886,
Zinoffsky had estimated the iron content of horse hemoglobin to be 0.335%. In 1937,
McCance and Widdowson came up with new concept that the amount of iron in the
body must be regulated by controlled absorption. (Underwood, 1971).
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II.C Iron in Body Tissue and Fluids:

The total iron content of the animal body varies with species, age, sex, nutrition, and
the state of health. Normal adult man is estimated to contain 4-5g of iron or 60-70ppm
of whole body of a 70 kg individual (Lamb et al. 1958). Most of the body iron is
present in complex form bound to proteins, either as porphyrin or heme compounds,
particularly hemoglobin and myoglobin, or as non-heme protein-bound compound
such as ferritin and transferrin. The hemoprotein and flavoprotein enzymes together
constitute less than 1% of total body iron. Free, inorganic iron is present in negligible
quantities (Lamb et al. 1958).
Among the organs and tissues of the body, the liver and spleen usually carry highest
iron concentration, followed by kidney, heart, skeletal muscles, pancreas, and brain
(Underwood, 1971).

II.D Dietary Sources of Iron:

The overall intake of iron from different diets varies greatly with the proportion of
iron-rich and iron-poor foods that they contain, with the degree of contamination with
iron to which they have been exposed, and, to some extent, with the locality from
which they are obtained. Average U.S. diet was reported to supply 12-15 mg iron per
day value, Australian diet, which is typically high in meat, have been estimated to
supply 14-20 mg iron. A typical poor Indian diet was shown to provide only 9 mg
iron, whereas improved diet containing less milled rice and more pulses and green
vegetables could provide as much as 60 mg iron/day (Underwood, 1971).
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The dietary source of iron influences the efficiency of iron absorption, which ranges
from <1% to >20% (Underwood, 1971). Non-heme iron in food of vegetable origin is
at lower end of the range, dairy products are in the middle, and meat is at the upper
end. About 10% of the small amounts of iron in unfortified formulas or whole milk is
absorbed. The iron content of the breast milk is same as that of cow’s milk, but about
50% of the iron in the breast milk is absorbed, hence breast milk is better sources of
iron than cow’s milk and unfortified formulas (Ziegler and Filer, Jr. 1996). Its better
absorption efficiency does not entirely make up for its low iron content, and after age
of 6 months breast-fed infants require an additional sources of iron to meet their iron
requirement (Ziegler and Filer, Jr. 1996)
Meat is good source of iron because much of it is in the form of heme-iron, which is
absorbed 2-3 times more than non-heme iron completely than non-heme iron (Ziegler
and Filer, Jr. 1996). In addition, it has been reported that factors in the meat promote
non-heme iron absorption from the entire meal (Ziegler and Filer, Jr. 1996).

II.E Iron Chemistry and Biochemistry:

The study for mechanism of iron absorption has been controversial, probably due to
the complex chemistry of the element and to the different capabilities of that
biological membrane have for iron uptake. Iron catalyzes great number of chemical
reaction and many of these reactions are related to the chemical nature of the element
which is characterized by two principle oxidation states: divalent iron (Fe II (d-6)) and
trivalent iron (Fe III (d-5)) and their associated ability to form complexes.
In water and in absence of oxygen, iron is present in the hexa-aqua complex divalent
ion, which is readily oxidized upon increasing oxygen concentration to trivalent aqua

6

complex of similar structure according to the one electron reversible reaction shown
below and oxygen become a source of free radicals:

Fe (II) aq + O2

Fe (III) aq + O2-.

The water solubility of trivalent hexa aqua-complex is function of pH and rapidly
decreased by increasing pH value from 1 to 9. Due to the complex hydroxylation
reactions of deprotonation of the aqua-complex, oxo-hydroxy species of decreasing
solubility are formed in water as shown in fig. below (Cremones P et al. 2002):

Fig. II.E.1. Hydrolytic reaction of iron as function of pH. At low pH values iron is
present in solution as free ion. Aqua complex oligomers are generated at pH values
higher than 2 and polymerization occurs by further increasing the pH; x is the
estimation of number of iron atoms present in the aquated form, y and z are the O- and
the (OH)- in the bridging position of the polynuclear core bonded to x by the
relationship 2y-z/p=n. Precipitation of these forms occurs at the x values higher than
20 (Cremones P et al. 2002).
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In biological media at low oxygen tension, Fe(OH2)62+ is the predominant species,
while Fe(OH2)63+ is minor species due to its low solubility (10-12mol/l at pH 7)
(Flynn, 1984; Cornell et al. 1989).
These chemical characteristics are suggestive, in principle that iron II derivative can
be taken up more easily than iron III derivative by cell membrane as a consequences
of more favorable solubility properties.

Iron balance and distribution:

Fig. II.E.2. Iron balance in man.
In normal conditions the mammals are able to maintain iron homeostasis by
controlling absorption from the diet and avoiding the overload (Fig 2). Appropriate
amounts of iron (10-15mg) in the diet are taken up in the intestinal mucosa (normally
1 mg/day) and transported by plasma ferritin to the utilization compartment (mainly

8

red blood cells) and the storage protein (ferritin) from which it can be mobilized when
required. Iron can be recycled within mammalian cells and any uncontrolled losses
from epithetical cells or via blood loss is balanced by the amount of absorbed iron.
The daily body turnover in healthy human is 1 mg and can reach 4-5 mg in
menstruating woman. Figure II summarizes the iron balance in man (Cremones et al.
2002):

II.F Iron Absorption:

II.F.1 Introduction:

Iron absorption normally occurs in the duodenum and upper part of jejunum. The
availability of ingested iron for absorption and the amount absorbed depends upon the
chemical nature and quantity of iron the diet, the presence of other factors in ingested
foods, the effect of gastrointestinal secretion and the absorptive capacity of the
intestinal mucosa. The absorptive capacity is regulated by two internal factors, the
size of the iron stores and the rate of erythropoiesis (Bothwell et al. 1979).

Iron absorption has been assumed to have an important role in regulation of iron
balance. Iron balance in the normal adult male is limited with an exchange of ~1
mg/day. Absorption from the test meal is high if iron stores are depleted and is
surpassed if iron stores are enlarged (Burke et al. 2001).
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II.F.2 Mechanism of Iron Absorption:

Dietary iron compounds are divided into two types, heme and non-heme iron. In
humans heme iron is absorbed more efficiently than non heme iron. Hence heme iron
may contribute a large amount of absorbed iron even though it represents a lesser
fraction of ingested iron. Heme and non-heme iron is absorbed in the body by
different mechanisms, which are described below.

II.F.3 Non-heme Iron absorption:

Non-heme (inorganic) iron is present in the diet as either reduced ferrous (Fe II) or
oxidized ferric (Fe III) form. Under normal physiological condition (i.e. neutral pH
and in presence of oxygen) ferrous iron is rapidly oxidized to ferric form and
precipitate as iron hydroxide. In the luminal contents of gut, iron is likely to be in the
ferric form and therefore poorly potentially bioavailable. Non-heme iron is absorbed
early in digestion mainly in the duodenum, where the low pH favors solubility.
Further down the intestine it is likely that the formation of insoluble ferric complex
reduces bioavailability. The transport of the non-heme iron across the duodenal
mucosa has been studied intensively over the years and is highly adaptive to change in
iron status (stores, erythropoiesis, and hypoxia). Much progress has been made in the
last few years in identifying the proteins involved in this process (Miret et al. 2003).

Non-heme iron is transported into the cell in the ferrous form, mainly by the carrier
DMT1 (Divalent Metal Transport 1), also known as natural resistance associated
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macrophage protein (Nramp2). Several steps are involved in non-heme iron
absorption, viz.
1. transport to erythrocytes across the brush border membrane
2. movement of the iron through the cell
3. transport across basolateral membrane (transfer step) and
4. passage through the interstitial space and capillary wall.
Two carriers are required, DMT1 for the uptake step and ferroportin 1/IREG1/MTP1
for the transfer step. Several other proteins have been shown to be involved in the
absorptive process, either directly or indirectly. A ferric iron reductase on the brush
border membrane, Dcytb, is believed to be responsible for the reduction of ferric to
ferrous form before uptake by DMT1 (Morgan and Oates, 2002). For optimal
transport of ferrous form, DMT1 also require a proton gradient provided by gastric
acid to co-transport ferrous iron. The intracellular movement of iron is poorly
understood but the copper containing ferroxidase, hephaestin (Hp) is involved (Valpe
et al. 1999).

II.F.4 Heme iron absorption:

Heme iron derived from meat is an important source of iron, and is highly potentially
bioavailable.
The absorption of hemoglobin and myoglobin derived iron differs from that of
inorganic iron. Most heme-iron enters the small intestinal absorptive cells as an intact
metalloporphyrin. Current evidence is that this is facilitated by heme receptor and
heme enters the cell via vesicle (Grasbeck et al. 1979). Once heme is within the cell,
iron is released from porphyrin by mucosal heme oxygenase so that it can enter the
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circulation as inorganic iron. Unlike non-heme iron, heme iron is soluble in alkaline
solutions and is precipitated as hematin in acidic milieu (Conrad et al. 1966). This
makes the chelation less important to maintain solubility in duodenum. There is
common intracellular pathway for heme and non-heme iron absorption, demonstrated
by competitive inhibition between simultaneously and sequentially administered heme
and non-heme iron (Hallberg and Solvell, 1967).

II.G Regulation of Iron Absorption:

Humans have limited capacity to excrete iron, so the amount or iron in the body is
controlled at the point of absorption in the proximal small intestine. The iron uptake
by mucosa cells and iron transfer into the carcass are significantly increased in iron
deficient animal as compared to iron overloaded animals (Adams et al. 1991). Thus
the uptake from the mucosa cell appears to be the main site of regulation of non-heme
iron absorption. Storage iron status is also a well known factor for regulation of iron
absorption. Enhanced erythropoiesis is another potent stimulus of iron absorption
(Anderson et al. 2005).

Early autoradiographic studies by Conrad and Crosby showed that the mature
epithelial cells of mid to upper villus are able to absorb iron from the diet; it is the
cells of intestinal crypts that are able to take up iron from the body (Conrad and
Crosby, 1963). The inference from this study is that the crypt cells are the ones that
respond to the body signals to modulate the intestinal iron absorption.
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The concentration of iron within the crypt cell is, thus, an important determinant of
iron absorption. The crypt cell iron concentration must, thus, reflect body iron needs
and must in turn modulate the expression of gene encoding proteins important for
vectorial iron transport across the mature enterocyte. The mechanism by which the
crypt cell’s intracellular iron concentration may respond is poorly understood.
Anderson studies the distribution and functions of the transferrin receptor in the small
intestine and have shown that most receptors are located at the basolateral membranes
of the intestinal crypt cells. These transferrin receptors are able to bind, internalize
and recycle transferrin to the cell surface and, in short, the crypt cells appear to
possess fully functional transferrin/transferrin receptor iron delivery system. These
studies have indicated that the transferring receptor provides one pathway by which
crypt cell could kept informed about body status, but one can not exclude the
possibility that the crypt cell could be informed in other ways or by additional signals
(Anderson, 1996).

The following figure shows the model for control if iron absorption.
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Figure II.G.1: Model for control of iron absorption. Signal from the body to
modulated iron absorption are received by epithelial cells of the intestinal crypt.
These cells are able to respond to the body signals but are unable to take up dietary
iron themselves. The body signals, perhaps by altering the intracellular iron status of
the crypt cells, determine the expression of the genes important for the absorption
process. The proteins encodes by these genes are expressed as functional membrane
transporters after the epithelial cells have migrated up the villus and matured into
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absorptive enterocytes. These cells are now able to transport dietary iron to the
circulation but appear to have little capacity to receive iron from the body (Anderson,
1996).

II.H The concept of Iron Bioavailability:

Iron bioavailability can be defined as the proportion of total mineral or total trace
element in food, meal, or diet, which is utilized for normal physiological body
functions. Various methods have been used to study the dietary bioavailability of iron
in man. The chemical balance technique is the only method that directly measures the
dietary iron absorption. That method, however, is insensitive, imprecise and time
consuming, and it gives no information about the iron absorption from different
meals.

The introduction of radioisotopes made it possible to label single food items
biosynthetically with radioiron.

Studies with labeled foods have shown that

absorption from individual food differs markedly. These differences in the
bioavailability are apparently related to differences in solubility, dissociation and
uptake of chemically uncharacterized iron compounds in foods.

In recent years some unexpected observations have provided the important
breakthrough and led to the development of extrinsic tag method. When single food
biosynthetically labeled with radioiron (intrinsic tracer) was carefully mixed with a
trace amount of iron salt labeled with another radioiron isotope (extrinsic tracer), the
observations was made that the absorption of two tracers, from such doubly labeled
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foods, was almost identical. The magnitude of absorption was different from different
foods and in different subjects, but the absorption from the extrinsic and intrinsic
tracers was the same in each subject. Based on these finding the concept of common
non-heme iron was introduced. This concept assumes that the non-heme iron
compound in different foods in a meal can be uniformly labeled by extrinsic inorganic
radioiron tracer (Hallberg, 1981). Heme iron cannot be labeled by extrinsic inorganic
tracer.

II.I Methods to Determine Iron Bioavailability:

Three methods are universally used for determination of iron bioavailability discussed
below:

II.I.1. In-vitro Method:

In in-vitro method the sample is subjected to pepsin and pancreatin digestion with a
dialysis bag of specific MWCO (Kane and Miller, 1984). The dialyzable iron is
measured after pancreatin digestion and accounted for potentially bioavailable form of
iron.
In this method the dialyzable iron is taken as potentially bioavailable form of iron, as
it is necessary for the iron to get bound to a ligand and cross the dialysis tube
membrane to get absorbed in human body.
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II.I.2. Caco-2 Cell Method:

Caco-2 cell line has properties similar to human intestinal cells, which are utilized for
determination of iron bioavailability. The caco-2 cultured plates are coupled with
inserts carrying a dialysis membrane of specific MWCO and placed in the digestion
sample (Swain et al. 2002). Once the digestion is over the uptake of iron by caco-2
cells is determined and accounted for potentially bioavailable forms of iron.
In this method the uptake of iron by Caco-2 cell is important as caco-2 cell line
resembles to human intestinal cell.

II.I.3. In-vivo Method:

In-vivo method refers to the use of living subjects to study iron bioavailability. In case
of animals, a specific diet, containing a stable isotope of iron called as radio labeled
iron, is added to meal externally and given to the subjects during the study period.
After the study period, the animal is sacrificed and hemoglobin concentration and
plasma iron concentration is estimated.

In case of humans, healthy volunteers are selected randomly and their hemoglobin
and plasma iron concentration is determined. Then the subjects are given the test meal
containing radio labeled iron at regular interval. The blood and fecal samples are
collected at regular intervals and analyzed for radio labeled iron. At the end of the
study the data is analyzed for difference in blood iron before and after study and iron
bioavailability is estimated by different available methods like WHO’s method
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(FAO/WHO 1988), Monsen’s method (Monsen et al. 1978), Tseng’s method (Tseng
et al. 1997) etc.

II.J. Individual factors affecting non-heme iron bioavailability:

II.J.1. Iron status:

The absorption of non-heme iron is markedly influenced by the iron status of the
subject – more iron is absorbed by the iron deficient and less by the iron-replete
subjects. This leads to marked subject to subject variability, which makes it difficult
to determine whether difference in test meal studied in different group subjects relate
to properties of the meals or to the iron status of the subject.

The effect of difference in iron status among different subjects can be adjusted by
obtaining independent measure of their absorptive capacity. This is accomplished by
determining the absorption from the standard dose of inorganic radioiron given at
physiological levels under standardized conditions (Hallberg, 1981).

There is good correlation between iron stores and serum ferritin, and it has been
shown that there is good correlation between serum ferritin and non-heme iron
absorption (Bezwoda et al. 1979). Therefore serum ferritin can also be used as an
alternative to the reference dose absorption. However, serum ferritin is only an
indirect measure of individual’s ability to absorb iron, and extraneous factors such as
minor infections may affect iron absorption and serum ferritin in opposite direction
(Hallberg, 1981).
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II.J.2. Pregnancy:

The bioavailability of dietary iron increases during pregnancy and is roughly parallel
to the increased iron requirements.

II.J.3. Disease States:

In gastric achlorhydria, the absorption of dietary non-heme iron is reduced in relation
to the absorption from ferrous iron salt (Rasmussen, 1981). After partial gastrectomy,
a decrease in bioavailability of non-heme dietary iron is often observed. The
magnitude of the decrease depends upon the type of the gastric operation performed
(Magnusson, 1979). In idiopathic hemochromatosis, the absorption of non-heme iron
marked increases in relation to the size of iron stores (Bezwoda, 1976).

II.K. Dietary factors influencing the bioavailability of non-heme iron:

II.K.1. Ascorbic acid:

It was shown early on that ascorbic acid or orange juice with a high content of
ascorbic acid markedly increases the food iron absorption. This effect is due to
promotion of non-heme iron absorption (Apte and Venkatachalam, 1965) and there is
no effect on absorption of heme iron. The absorption increase is related to the amount
of ascorbic acid. A significant effect can be observed with only 25 mg of ascorbic
acid, which is amount present in a third of the glass of orange juice. Orange juice
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containing 70 mg ascorbic acid increased iron absorption from breakfast meal 2.5
times (Rossander et al. 1979).

In summary, ascorbic acid is very potent promoter of non-heme iron absorption.
Crystalline ascorbic acid and native ascorbic acid have about the same promoting
effect. Cooking and baking can destroy the ascorbic acid and hence its effect on iron
absorption. The effect of ascorbic acid seems to be independent of the effect of other
promoters, such as meat. However when two promoters are present the effect of each
promoter will be smaller as compared to when it is present alone. In the presence of
inhibitor of non-heme iron, such as tea, the relative enhancing effect of ascorbic acid
on non-heme iron absorption is same (Hallberg, 1979).

The effect of ascorbic acid may be related both to its reducing effect, preventing the
formation of insoluble ferric hydroxide, and to its effect on forming soluble
complexes with ferric iron, which preserve the iron solubility in more alkaline
duodenal pH (Conrad and Schade, 1968).

In recent study (Engle-Stone et al. 2005) it has been shown that meat and ascorbic
acid can promote iron availability from iron-phytate but not from iron-tannic acid
complexes.

II.K.2. Meat and Fish:

An enhancing effect of meat and fish was first time reported by Layrisse et al. in 1968
and confirmed by many other studies (Taylor et al. 1986; Morrissey, 1998; Seth and
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Mahoney, 2000; Swain et al. 2002). The absorption-promoting effect of meat is dose
related (Underwood 1971). The enhancing effect of meat on iron bioavailability is
termed as ‘meat factor’. Several investors have tried to clarify the mechanism of this
meat effect. Many components such as amino acids, histidine (Swain et al. 2002),
histidine residue (Mulvihill and Morrissey, 1998; Seth and Mahoney, 2000),
carbohydrate fractions (Rozo et al. 1986, Huh et al. 2004), sulfhydryl (Taylor et al.
1986) etc have been reported to be responsible for enhancing effect on iron
absorption.

II.K.3. Tannates:

It has been reported that tea markedly reduced the iron absorption of non-heme iron
absorption from foods. The absorption from bread was reduced to one third and from
soup to one fourth when served with tea compared with water (Disler et al. I 1975).
This effect has been attributed to the formation of iron-tannate complex. It has also
been reported that the tannins may be partly responsible for low bioavailability of iron
in many vegetable foods (Disler et al. II 1975). Tannates are also present in coffee and
it is possible that inhibiting effect of coffee is due to tannates.

II.K.4. Phytates, phosphates and fibers:

Several studies have shown that the sodium phytate decreases iron absorption in man
(Hallberg and Solvell, 1967; McCance et al. 1943). The lower fraction of iron
absorbed from brown bread compared with white has been attributed to the high
content of iron phytates in bran (Moore, 1968). Most of the phytate, however, is
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broken down during leavening and baking of bread, with corresponding increase in
inositol. The final content of phosphate in wheat is not such of magnitude that it can
affect the iron absorption with increasing amounts of bran. It has been suggested that
the inhibiting effect of bran is due to its content of fiber components (Rasmussen,
1974). Monoferric phytate, prepared from wheat, bran have been reported to have
higher bioavailability for rats (Morris and Ellis 1976).

II.K.5. Egg and Milk:

Eggs have been reported to decrease the absorption of iron. Egg yolk has been
reported to decrease the absorption of iron from inorganic salt (Elwood 1968).
Milk has been found to decrease the iron absorption from meals with low
bioavailability.

II.K.6. Organic Acids:

Salovara et al. have observed that organic acids show a concentration-dependent
influence on the uptake of ferrous and ferric iron in Caco-2 cells (Salovara et al.
2002). Results obtained by Salovara et al. showed a correlation between absorption
pattern and chemical structure of the acids. Accordingly, four-carbon dicarboxylic
acids, such as tartaric, malic, succinic, and fumaric acid, showed a positive effect on
both ferric and ferrous iron absorption in the cells, but to varying degrees. The
number of hydroxyl groups was shown to be important. Citric, lactic, and oxalic acid
(2-, 3-, and 5-carbon carboxylic acids) had a similar and very negative effect on
ferrous iron and a positive effect on ferric iron absorption. Acetic and propionic acid,
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which are simple 2- or 3-carbon monocarboxylic acids, showed a positive effect on
ferrous iron and no effect on ferric iron uptake (Salovara et al. 2002).

In a review, oxalate has been reported to decrease in iron bioavailability (Conrad,
1970).

Succinic acid, which increases the iron absorption from pharmaceutical doses of iron,
has about the same 35% absorption-promoting effect on dietary non-heme iron in
standard meal, when given in the amount of 150 mg (Hallberg, 1979).

II.L. The concept of ‘Meat Factor’:

The concept of ‘meat factor’ was established when Layrisse et al. showed that the
absorption of iron from different vegetable foodstuff was markedly increased when
they were served with meat and fish (Layrisse et al. 1969). This observation has been
confirmed by number of studies both in-vitro and in-vivo (Amine and Hegsted, 1971;
Monsen and Cook 1979; Kane and Miller, 1984; Slatkavitz and Clydesdale, 1988). It
is evidence that meat and fish promote inorganic iron absorption. However, the
mechanism by which meat acts to promote absorption of non-heme iron from diet is
still unknown. Several factors have been proposed to be responsible for meat factor
and are summarized below.

II.L.1. Sulphydryls:

Hamed et al. suggested that the sulphydryl (-SH) groups of cysteine and glutathione
are capable of reducing Fe(III) to Fe(II) at low pH (Hamed et al. 1983). Kirwan et al.
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suggests that –SH rich myofibrillar fractions of meat, in particular, the heavy
meromyosin fractions may be a component responsible for meat factor (Kirwan et al.
1993). Mulvihill and Morrissey studied the effect of –SH content of animal proteins
on production of dialyzable iron and showed that the –SH content of meat plays
important role in this indicator of iron bioavailability (Mulvihill and Morrissey,
1998).

Mulvihill et al. showed that heavy meromyosin, which has 25 –SH residue per
molecule, produces more amount of dialyzable iron than light meromyosin molecule,
which has 4-5 –SH residue per molecule (Mulvihill et al. 1998).

Taylor et al. studied the effect of cysteine containing peptides released during the
meat digestion on iron absorption in humans. In this study the sample was divided
into two batches: in first batch the thiol groups of cysteine residues were preserved
and in second batch the thiol groups were oxidized to cystine. The extracts were given
to the subjects in form of a soup. The hemoglobin and serum ferritin concentration of
the subjects was analyzed. The results obtained from this study suggested that the
enhancing effect of meat on non-heme iron absorption is due to cysteine containing
peptides, like glutathione, and not the free amino acids (Taylor et al. 1986).

II.L.2 Histidine:

Seth and Mahoney studied the role of histidine residue in chelation of iron by peptides
from chicken muscle proteins in-vitro and concluded that histidine residue do
contribute to iron chelation and could be involved in promotion of iron absorption by
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muscle tissue (Seth and Mahoney, 2000). Swain et al. used Caco-2 cells method to
study influence of beef protein on iron absorption and suggested that the enhancement
of non-heme iron absorption of beef may be due to peptides produced during
gastrointestinal digestion and that histidine content may be important factor
contributing to this effect (Swain et al. 2002).

II.L.3. Protein Digestibility:

The importance of protein digestibility in promoting iron bioavailability has been
addressed by many investigators (Bothwell et al. 1979; Kane and Miller, 1984;
Slatkavitz and Clydesdale, 1988). Rasmussen and Hallberg studied the effect of
animal proteins on the absorption of food iron in man and concluded that absorptionpromoting effect of meat proteins may result from the peptides formed during
digestion (Rasmussen and Hallberg, 1979). Kane and Miller (Kane and Miller, 1984)
investigated the effect of selected proteins on iron-bioavailability in-vitro and came
up with a conclusion that protein and iron interactions occur during the digestion and
results in iron absorption.

Mulvihill and Morrissey showed that low molecular weight digestion products
enhance iron bioavailability in-vitro, while large molecular weight products may bind
iron and hence depress its bioavailability and concluded that the small molecular
weight protein degradation products may contribute to ‘meat factor’ (Mulvihill and
Morrissey, 1998). Mulvihill et al. suggested that the myofibrillar protein fraction, in
part, may be responsible for the enhancing effect of meat on the in-vitro
bioavailability of non-heme iron (Mulvihill et al. 1998). Kapsokefalou and Miller
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concluded that the protein digestibility may be an important factor for iron
bioavailability in-vitro as more completely digested the protein is, more thiol groups
would be exposed and available for reducing iron (Kapsokefalou and Miller, 1991).
Conflicting results were obtained by Huh et al., who stated that the protein digestion
is not necessary for iron bioavailability and carbohydrate fractions, which are
extracted at low pH, are responsible for iron bioavailability in cooked fish muscle
(Huh et al. 2004)..

II.L.4. Carbohydrates:

It has been suggested that the absorption of radioiron is markedly influenced by the
kind of dietary carbohydrate (Amine and Hegsted, 1971). Amine and Hegsted found
that iron utilization is greatest with diets containing lactose, less in diets containing
sucrose and least with diets in which carbohydrate supplied was starch. However the
effect of carbohydrates was not uniform when different iron sources were used
(Amine and Hegsted, 1975). Rozo et al. studied effect of some carbohydrates on iron
absorption in rats and found observed that rats fed with high starch meal resulted in
reduction in iron absorption, whereas glucose, fructose and lactose enhanced iron
absorption (Rozo et al. 1986). Huh et al. studied the effect of cooked fish on iron
uptake and found that the acid extract, which contained high amounts of
carbohydrates and negligible amounts of proteins and amino acids, increased iron
uptake up to 4.9 fold by Caco-2 cells (Huh et al. 2004). Huh et al. also proposed that
the carbohydrates responsible for iron uptake may be oligosaccharides from
glucosaminoglycans which is present in the extracellular matrix of muscle tissue (Huh
et al. 2004).
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II.M. Effect of Cooking on ‘Meat Factor’:

The literature review suggests that the effect of cooking on iron bioavailability has not
been given much emphasis upon. The research by Baech et al. investigated the effect
of cooking temperature of pork on iron bioavailability. Pork was prepared in the form
of meat patties and packed into hermetically sealed aluminum cans. These cans were
divided into three different batches and the cans were exposed to one of the three heat
treatments as follows: by circulating the water at 70/95oC for 60 mins till the final
centre temperature reached 69.94oC and maximal heat treatment at 120oC in an
autoclave. The patties were given along with a phytate rich meal to the test subjects
and the serum ferritin and hemoglobin concentration was measured at the end of the
study. The cysteine content of the heated samples dropped by 19%, but the iron
bioavailability was not affected. The study concluded that the cooking temperature
does not affect non-heme iron absorption (Baech et al. 2002). But in this study the
meal was phytate rich, and it is well established that phytate is iron absorption
inhibitor (Hurrel et al. 1992) and may interfere with the study.

Another study by Huh et al. suggested that carbohydrate fractions from cooked
lyophilized fish promote iron bioavailability. The HPLC analysis of the extract
showed that the content of protein and amino acid was negligible and the fraction was
highly rich in carbohydrates (Huh et al. 2004). But the fish muscle was not heated
under controlled temperature conditions, which may have destroyed thiol groups
which are suggested to be responsible for meat factor. This study suggested that
carbohydrates in chicken may also have some effect of iron bioavailability, and to
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investigate the effect of carbohydrates on iron bioavailability, if there is any, is also
one of the aims of this study.

Based on the literature findings, the aim of this work is to investigate the effect of
heating temperatures on production of potentially bioavailable forms of iron and the
specific components of chicken, if any, affecting the bioavailability of iron.
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CHAPTER III
MATERIALS AND METHODS

III.A. Introduction:

Literature survey clearly mentioned that animal protein has a positive effect on iron
absorption. But, there is very little evidence for effect of cooking chicken muscle on
iron absorption. Using a standard model which involves only pepsin and pancreatin
enzymes and water besides the different cooked samples was thought to be a better invitro model to determine the effect of cooking chicken muscle on iron bioavailability
as compared to other in-vitro methods available. Production of dialyzable iron was
determined for preliminary samples of cooked chicken to evaluate the consistency and
reliability of the methodology.

III.B. Chemicals:

All chemicals were of analytical grade.

Water: Distilled-deionized water (DDW) was prepared using a Bantam Demineralizer
Model BO-5 (Branstead Company, Boston, MA) with an ultrapure cartridge
(Branstead International, Dubuque, IA, USA). DDW was used throughout the
experiments.
Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO,
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w).
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Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO,
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of
1:50 (w/w)
PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the
concentration of 50mg/ml, were dissolved in 50 ml of this buffer.
Dialysis tubing (Spectrum Labs Inc. Gardena, CA, USA): Spectra/Pro1 membrane
tubing with a diameter of 20.4 mm and a MWCO of 6,000 - 8,000 Da was used for
dialysis. Twenty centimeter length membrane tubes were cut and soaked in 5 mM
EDTA solution in DDW for at least 2 hrs and rinsed several times with DDW to
remove all the EDTA prior to use.
Reducing Protein Precipitant Solution: 100g of crystalline trichloroacetic acid (TCA),
50g of hydroxylamine • hydrochloride and 100 ml of 12N HCl were brought to 1 L
with DDW.
Non-reducing Protein Precipitant Solution: 100g of TCA and 100 ml of 12N HCl
were brought to 1 L with DDW.
Ferrozine Reagent: 3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine
monosodium salt. (Sigma Chemical Co. St. Louis, MO, USA P-9762). Ferrozine was
dissolved in DDW to prepare a 9 mM solution.
Ammonium Acetate Buffer: Ammonium Acetate ACS reagent was dissolved in DDW
and brought to a concentration of 10% (w/v).
Iron Solution (Fisher Chemical Fair Lawn, NJ, USA): Iron reference solution, suitable
for atomic absorption spectroscopy, at a concentration of 1000 ppm (as ferric nitrate
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in 2% of nitric acid), was used to prepare the standards as well as to add to the protein
samples as the source of extrinsic iron.
Biuret Reagent: The reagent was prepared by separately dissolving 1.50g of CuSO4 •
5H2O in 250 ml of DDW and 6.00g of sodium potassium tartrate (NaKC4O6 • 4H2O)4,
in 250 ml of DDW. Both the solutions were mixed and 300 ml of 10% (w/v) NaOH
was added and the final volume was made to 1 L with DDW.
Bovine Serum Albumin (BSA): Crystalline and lyophilized bovine serum albumin
prepared from fraction V, essentially globulin-free. (Sigma Chemical Co. St. Louis,
MO, USA A-7906). BSA was dissolved in DDW and made to concentrations ranging
from 1-10 mg/ml when used as a reference protein in the protein standards.

III.C Apparatus

Glassware: All glassware was acid washed with 2N HCl, rinsed with DDW several
times and oven dried.
Spectrophotometer: Perkin Elmer, Hitachi Model 200 UV-Vis, Coleman Instruments
Division, Oak Broo, IL, USA.
Low Speed Centrifuge: Bench top centrifuge Damon IEC model HN-S II.
High Speed Centrifuge: Sorvall Superspeed RC-58 Automatic refrigerated centrifuge,
Ivan Sorvall Inc., Newton, CT, USA.
pH Meter: Corning, Model 125, Corning Medical, Medfield, MA, USA with an epoxi
body combination electrode, Sensorex, Stanton, CA, USA.
Water Bath Shaker: Temperature controlled, Model 406015 Serial, American Optical,
Buffalo, NY, USA.
Blender: Waring Commercial Blender, Model # 51BL31, Torrington, CT, USA.
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Freeze Dryer: Virtis Company Inc, Model # 203314, Garinder, NY, USA.
Chest Freezer: So-Low, Environmental Equipment Company, Cincinnati, OH, USA.

III.D. Sample preparation:

III.D.1. Raw Chicken Muscle Sample:

Fresh, unfrozen chicken was purchased from local supermarket and the fat was
removed. This sample was homogenized with twice the weight of water for 3 min
with 1 min interval. After homogenization, 100g of sample was poured into container
and frozen to -40oC in a chest freezer.

III.D.2. Cooked Chicken Muscle Sample:

Fresh, unfrozen chicken was purchased from local supermarket and the fat was
removed. This sample was homogenized with twice the amount of water for 3 min
with 1 min interval. This slurry was heated in a boiling water bath till the temperature
reached 165 or 195oF with continuous stirring to maintain the uniform temperature of
the sample. Then the sample was again homogenized for 30 sec and 100g of sample
was poured into 1 pound plastic container, ~1 cm thick and frozen to -40oC in a chest
freezer.

The frozen samples were lyophilized using a Virtis company lyophilizer, at -40oC
with increase of 10oC every hour till the temperature reached 20oC and this
temperature was maintained until the sample was dried thoroughly. The lyophilization
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time for raw and cooked sample was 72 hrs and 48 hrs respectively. The end point
was when the chicken layer started sticking (puffing) out from the surface of the
container.

A detailed outline for the preparation of the sample is shown in following figure.
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Chicken Breast Muscle

Remove Fat

Homogenize (~ 3 min with one min
interval)

Cook in boiling water bath at
1650F/195oF (0.75lb/~ 50
mins)

Fill In Containers

Freeze to -400C
Homogenize ~30 secs
Lyophilize
Fill in containers (0.8-1.0cm
height)

Cool to room temp ~30 min

Freeze to -400C

Lyophilize

Figure III.D.2.1: Outline for lyophilization of raw and cooked chicken muscle sample
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After lyophilization, the sample was removed from the container and blended for 1
min in a coffee blender and analyzed for protein content using Micro Dumas method
(Ma and Rittner 1979).

III.E. Pepsin digestion:

The portion of the sample containing 2g of protein was mixed with DDW and the
weight was adjusted to ~ 90g, following which the pH of the suspension was adjusted
to 2.5 using 6.0 M HCl. 37.5 µM (1.4 ml) of Iron reference solution was added to this
suspension. The pH of this suspension was adjusted to 2.0 and the weight was
adjusted to 95g. This preparation was allowed to stand for 10mins. The final pH was
rechecked and adjusted to 2.0, if required. The sample at pH 2.0 was then placed in a
shaking water bath at 37oC for 5 mins. After this, 5ml of pepsin was added and the
suspension was incubated at 37oC for 2 hrs. Three similar digests of 100g were
incubated simultaneously in the same water bath. After pepsin digestion, the sample
was removed from the water bath and placed in a ice bath to stop the pepsin digestion.

III.F. Titratable acidity:

Titratable acidity is the amount of 0.5 N NaOH required to bring the pH of pepsindigested sample to 6.5. The equivalent moles of NaHCO3 are then added to the actual
digest to bring the pH to 6.5.
A 20g aliquot of the pepsin-digested sample from each of the 100g flask was taken
and 5 ml of pancreatin and bile in PIPES at pH 6.5 was added. The pH of this
suspension was then adjusted to 6.5 using 0.5N NaOH drop-wise. The suspension was
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allowed to stand for 10 min and the pH was readjusted to 6.5. The total amount of
NaOH required for this was used to calculate the equivalent moles of NaHCO3
required in 20 ml of the solution to be added to the dialysis tubing to bring the pH to
6.5.

III.G. Pancreatin digestion:

For pancreatin digestion two 20g samples of the pepsin-digested sample from each
flask were taken in 250 ml conical flasks, thus giving a total of six pancreatin
digestions. Dialysis tubing, 20 cm in length and containing 20 ml NaHCO3 solution at
the concentration determined by titratable acidity were added to the flasks. After 30
min of incubation at 37oC the pH was recorded and 5 ml of pancreatin/bile salt in
PIPES was added to each of the flasks incubated at 37oC for 2 hrs.
Following which the digests were removed and the contents inside and outside the
dialysis bags were weighed. The final pHs of the dialyzate and non-dialyzate were
recorded.

Analysis:

After the completion of pancreatin digestion, both the dialyzate and the non-dialyzate
were weighed and centrifuged at 1800 x g for 10 mins. Following which an aliquot
from each of the samples was mixed with non-reducing solution at 1:1 ratio (v/v).
These samples were used to quantify the amount of dialyzable ferrous and total
ferrous iron produced during the digestion process. Similarly an aliquot of each of the
samples was mixed with reducing solution at 1:1 ratio (v/v). These samples were used
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to quantify the amount of total dialyzable and soluble iron produced during the
digestion process. A reagent control was also prepared with the same ratio of reducing
and non-reducing solutions with the dialyzate or non-dialyzate being replaced by
DDW. These samples were covered and left on the bench at room temperature for
analysis of iron and protein on the following day.

All the samples were centrifuged. The samples containing the dialyzable portion were
centrifuged at 3500 RPM for 10 mins using the bench top laboratory centrifuge, while
the samples containing the non-dialyzable portion were centrifuged at 9,000 x g for 20
mins.

III.H. General Analysis Methods:

III.H.1. Dialyzable Ferrous Iron:

This represents the amount of dialyzable iron present in the ferrous form. This is the
most potentially bioavailable form of iron and so is the best indicator of potentially
bioavailable iron in in-vitro studies.

For the determination of dialyzable ferrous iron, 1ml aliquot of the samples having a
1:1 ratio of dialyzable digest : non-reducing solution, were taken in acid washed test
tubes. To this 2 ml of 10% ammonium acetate buffer was added, followed by the
addition of 0.5 ml of Ferrozine reagent. The mixture was mixed with a vortex and the
absorbance was measured immediately at 562 nm.
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III.H.2. Dialyzable Total Iron:

This represents the amount of dialyzable iron present in both the ferrous and the ferric
form. This is the indicator of the amount of absorbable iron as this is the iron bound to
the low molecular weight ligands and so gets easily dialyzed through the 6,000 8,000 Da cut off dialysis tubing.

For the determination of dialyzable total iron, 1ml aliquot of the samples having a 1:1
ratio of dialyzable digest : reducing solution, were taken in acid washed test tubes. To
this 2 ml of 10% ammonium acetate buffer was added, which was followed by the
addition of 0.5 ml of Ferrozine reagent. The mixture was mixed using a vortex,
allowed to stand at room temperature for one hour, and then the absorbance was
measured at 562 nm.

III.H.3. Non-dialyzable Ferrous Iron:

This represents the amount of iron being converted to the ferrous form but was not
dialyzable. This is an excellent indicator of the ability of the test protein or any other
component of investigation, to convert ferric iron to the ferrous form, which is the
most potentially bioavailable form of iron.

For the determination of non-dialyzable ferrous iron, 1ml aliquot of the samples
having a 1:1 ratio of non-dialyzable digest : non-reducing solution, were taken in acid
washed test tubes. To this 2 ml of 10% ammonium acetate buffer was added, followed
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by the addition of 0.5 ml of Ferrozine reagent. The mixture was mixed with a vortex
and the absorbance was measured immediately at 565 nm.

III.H.4. Non-dialyzable Total Iron:

This represents the amount of iron being converted to the soluble form but was not
dialyzable. This is an excellent indicator of the ability of the test protein or any other
component of investigation, to prevent polymerization of iron and convert it to the
soluble form, which is one of the prerequisites for the iron to become potentially
bioavailable.

For the determination of non-dialyzable total iron, 1ml aliquot of the samples having a
1:1 ratio of non-dialyzable digest : reducing solution, were taken in acid washed test
tubes. To this 2 ml of 10% ammonium acetate buffer was added, followed by the
addition of 0.5 ml of Ferrozine reagent. The mixture was mixed with a vortex,
allowed to stand at room temperature for 1 hour and the absorbance was measured at
565 nm.

III.H.5. Dialyzable Protein:

This represents the amount of protein, which has been finely digested and converted
into peptides within the 6,000 to 8,000 Da range or less, and hence could not be
precipitated by trichloroacetic acid (TCA). These are referred to as Low Molecular
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Weight Components (LMWCO), and it is a prerequisite to bind iron and carry it along
with them through the 6,000 - 8,000 Da cut off dialysis tubing.

For the determination of dialyzable protein, 1 ml aliquot of the samples having a 1:1
ratio of dialyzable digests : non-reducing solution, were taken in clean test tubes. To
this 4 ml of biuret reagent was added. The mixture is thoroughly mixed with a vortex,
allowed to stand at room temperature for 30 mins and the final absorbance was
measured at 540 nm. A blank value was obtained with 1 ml distilled water and 4 ml of
biuret reagent.

III.H.6. Non-Dialyzable Protein:

This represents the amount of protein, which has been completely digested and is
greater than the 6,000 - 8,000 Da range, but could not be precipitated by trichloro
acetic acid (TCA) and hence remains soluble. These are referred to as High Molecular
Weight Components (LMWCO), and have tendency to bind iron but cannot carry the
iron along with them through the 6,000 - 8,000 Da cut off dialysis tubing.
For the determination of non-dialyzable protein, 1 ml aliquot of the samples having a
1:1 ratio of non-dialyzable digests : non-reducing solution, were taken in clean test
tubes. To this 4 ml of biuret reagent was added. The mixture was thoroughly mixed
with a vortex, allowed to stand at room temperature for 30 mins. and the final
absorbance was measured at 540 nm. A blank value was obtained with 1 ml distilled
water and 4 ml of biuret reagent.
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III.H.7. Sulfhydryl Analysis:

The total sulfhydryl content of lyophilized raw and cooked (165oF and 195oF) sample
was determined using Ellman’s method (Ellman 1959). Protein at a concentration of
2mg/ml was dissolved in Na-phosphate buffer pH 8.0. 2ml of this sample was mixed
with 18ml of 2.2% SDS in phosphate buffer pH 8.0. Ellman’s reagent (DTNB) at the
concentration 0.1% was dissolved in phosphate buffer pH 8.0 and 0.1ml was added to
3ml of blank/sample and the absorbance was read at 412 nm after 30 min against
phosphate buffer. For the reagent blank, 3 ml of phosphate buffer was mixed with 0.1
ml of Ellman’s reagent and the absorbance was read at 412nm against phosphate
buffer and subtracted from each sample reading.

III.8. Histidine Analysis:

Histidine was analyzed using the method described by Seth and Mahoney (Seth and
Mahoney, 2000). Protein at the concentration 10mg/ml was dissolved in phosphate
buffer pH 6.5. 2ml of this sample was mixed with 18ml of 2.2% SDS in phosphate
buffer pH 6.5. Diethyl-pyrocarbonate (DEPC) reagent at the concentration 20mM was
dissolved in absolute (anhydrous) ethanol and 50 µl was added to the 1ml of
blank/sample and the absorbance was read at 240nm after 30 min against phosphate
buffer. For blank, 1 ml of phosphate buffer was mixed with 50 µl DEPC reagent and
the absorbance was read at 240nm against phosphate buffer.
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III.I. Controls:

III.I.1. Iron Only Control:

Digestion system without protein sample and enzymes was used carry out iron only
control to compare the values with non-digested samples. The procedure was
followed exactly as that mentioned above to obtain the values for dialyzable and nondialyzable iron.

III.I.2. Iron-Pepsin control:

Digestion system with pepsin and iron but without protein sample and pancreatin
enzyme was used to get the values for dialyzable ferrous, dialyzable total, total
ferrous and total soluble iron. The procedure was followed exactly as that mentioned
above to get the respective values.

III.I.3. Iron pepsin pancreatin control:

Digestion system with pepsin, pancreatin enzymes and iron but without protein
sample was used as control to ascertain the authenticity of the digestion processes and
to calculate the extrinsic amount of iron that contributes to the measured values of
iron after digestion. The procedure was followed exactly as that mentioned above to
obtain values for dialyzable and non-dialyzable iron.
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III.I.4. Endogenous Control:

Endogenous control was used to estimate the contribution of intrinsic iron present in
the samples. Digestion system with protein sample, pepsin and pancreatin enzymes
and without standard iron solution was used to carry out endogenous control. The
procedure was followed exactly as that mentioned above to obtain values for
dialyzable and non-dialyzable iron and these values were subtracted from
corresponding values for digested samples.

III.I.5. Non-digested control:

Non-digested control was used to estimate how much iron is produced without
digestion of chicken muscle and to determine if digestion is important factor in iron
bioavailability. For non-digested samples, the exact procedure as that of digestion was
followed without adding any enzymes.

III.J. Calculations:

The amount of dialyzable and non-dialyzable matter obtained after each digestion
were recorded and used to calculate dialyzable ferrous, total ferrous, total dialyzable
and total soluble iron.

As the dialysis process is known to be an equilibrium process, the amount of
dialyzable iron is distributed equally in the entire volume of liquid present inside the
dialysis tubing and in the non-dialyzate during digestion. So the total volume for the
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dialysis would be 45 ml (20 ml for dialysis bag content, 20 ml for non-dialyzate and 5
for PIPES/bile).

Therefore the total volume of dialyzate (VD) = 45 ml.

The amount of non-dialyzate always varies depending upon the dynamics of the
system. If the sample contains very high amount of carbohydrates, then the osmotic
pressure is very high and amount of liquid coming out of dialysis bag is high and
vice-versa. So this amount is determined by weighing non-dialyzate and dialysis bag
content. Assuming the density to be one, the same amount is taken as volume of nondialyzate and dialyzate produced. This volume generally varies from 26-28 ml.

Therefore the total volume of dialyzate (VND) = 26-28 ml.

The concentration of iron present in the dialyzate and non-dialyzate is calculated
using ferrozine method as µg/ml, this can be represented as CFeF for ferrous and CFeT
for total iron iron concentration.

Therefore,
Dialyzable ferrous iron = CFeF dialyzate * VD
Non-dialyzable ferrous iron = CFeF non-dialyzate * VND
Total dialyzable iron = CFeT dialyzate * VD
Total non-dialyzable iron = CFeT non-dialyzate * VND

And,
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Total ferrous iron = Dialyzable ferrous iron + Non-dialyzable ferrous iron
Total soluble iron = Total dialyzable iron + Total non-dialyzable iron.

Similar calculation will be used to calculate the dialyzable protein and total protein
content after TCA precipitation.
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CHAPTER IV
EFFECT OF FREEZING AND LYOPHILIZATION ON PRODUCTION OF
DIALYZABLE IRON BY RAW CHICKEN MUSCLE

IV.A. Introduction:

Literature survey showed that most of the researchers used lyophilized meat samples
to maintain the uniformity of samples throughout the study (Baech et al. 2002). Also,
there is no data showing the effect of individual processes like freezing and
lyophilization on iron bioavailability of chicken muscle samples. Sulfhydryl groups (SH) (Hoffman and Hamm 1978) and cysteine (Taylor et al. 1986) containing peptides
of meat have been suggested to be responsible for ‘meat factor’. The effect of freezing
and lyophilization on these factors is not mentioned in the literature. Freezing and
lyophilization processes are very complex, and may cause some structureconformational changes and oxidation of –SH groups in the chicken muscle, because
of which the ability of chicken muscle to produce potentially bioavailable forms of
iron may be affected.

Taking above factors into account, this chapter will focus on the effect of freezing and
lyophilization on production of dialyzable iron, an important marker of potentially
bioavailable form of iron in in-vitro studies. Slurry of raw chicken muscle sample was
formed as mentioned in methods and it was divided into three batches. One batch was
kept refrigerated, one was frozen at -40oC and one was lyophilized. The values for
dialyzable iron were obtained and compared.
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IV.B. Materials and Methods:

IV.B.1. Chemicals:

As discussed in Chapter III except for freshly prepared,

Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO,
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w).

Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO,
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of
1:50 (w/w)

PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the
concentration of 50mg/ml, were dissolved in 50 ml of this buffer.
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IV.B.2. Sample Preparation and Digestion Protocol:

As described in chapter III, except where specifically noted.

IV.C. General Analysis Methods:

As described in chapter III, except where specifically noted.

IV.D. Controls:

As described in chapter III, except where specifically noted.

IV.E. Results and Discussion

This section presents the iron and protein values of refrigerated, frozen and
lyophilized raw and chicken samples in comparison with control. The endogenous
control values were subtracted from each digested sample.

Table 1 shows the values for total sulfhydryl and histidine content of refrigerated,
frozen and lyophilized raw chicken muscle sample.
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SAMPLE

Total –SH Content in
mM/g Protein

Total Histidine Content in
mM/g Protein

Refrigerated

131.7 ± 7.96 a

161.6 ± 3.25 c

Frozen

124.8 ± 6.58 a

162.0 ± 1.99 c

Lyophilized

96.0 ± 4.23 b

150.0 ± 3.31 d

Table IV.E.1: Total sulfhydryl and histidine content for refrigerated, frozen and
lyophilized raw chicken muscle samples. Mean ± SD of total sulfhydryl and histidine
content of 6 samples (n = 6) in mM/g protein. Different subscripts indicates difference
using One Way ANOVA test for α = 0.05 or 95% confidence.
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Figure IV.E.1: Total sulfhydryl and histidine content of refrigerated, frozen and
lyophilized raw chicken muscle samples. Graphical representation of the data from
table 1.

The total sulfhydryl and histidine content of refrigerated, frozen and lyophilized raw
chicken muscle sample is shown in figure 1. There was no significant difference
between total sulfhydryl and histidine content of refrigerated and frozen raw CMS.
However, there was a significant loss of 32% for total sulfhydryl content after
lyophilization of raw chicken muscle. Also, the histidine content of raw chicken
dropped by ~6% after lyophilization. These results indicated that lyophilization causes
a significant loss in sulfhydryl content, which may be either due to polymerization of
proteins because of loss of water or due to oxidation of –SH groups during
lyophilization. These results also showed that there was a drop in histidine content for
raw chicken after lyophilization, which is the new finding as it is not mentioned
anywhere in the literature.
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Table 2 shows the values for total dialyzable iron and dialyzable ferrous iron
produced by non-digested raw chicken sample for refrigerated, frozen and lyophilized
treatments.

SAMPLE

Total Dialyzable iron in
µg

Dialyzable Ferrous Iron in
µg

Control

3.4 ± 0.52 a

2.0 ± 0.46 d

Refrigerated

38.1 ± 1.83 b

16.8 ± 1.21 e

Frozen

34.2 ± 0.89 b

15.1 ± 0.90 e

Lyophilized

19.4 ± 0.45 c

3.8 ± 0.96 a

Table IV.E.2: Total dialyzable iron and dialyzable ferrous iron produced by nondigested control and raw refrigerated, frozen and lyophilized chicken muscle samples.
Mean ± SD of total dialyzable iron [Fe (II) + Fe (III)] and dialyzable ferrous iron in
µg for total 6 pancreatin digestions (n = 6). The total amount of iron used for each
pancreatin digestion is 279 µg. Different subscripts indicates difference using One
Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced by the
same amount of samples has been subtracted from all the values.
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Figure IV.E.2: Production of total dialyzable iron and dialyzable ferrous iron by nondigested control and raw refrigerated, frozen and lyophilized chicken muscle samples.
Graphical representation of the data from table 2. TDI: Total Dialyzable Iron; DFI:
Dialyzable ferrous iron.

The total dialyzable iron and dialyzable ferrous iron produced by non-digested
samples of raw refrigerated, frozen and lyophilized CMS is shown in figure 2. Raw
refrigerated and frozen chicken produced about 11 times higher amount of total
dialyzable iron as that of control. Lyophilization of raw CMS caused a significant loss
of ~50% for total dialyzable iron. Dialyzable ferrous iron produced by refrigerated
and frozen raw chicken was 8 times higher than that of control. After lyophilization of
raw chicken only 25% of dialyzable ferrous iron was produced as compared to
refrigerated and frozen chicken sample. The values obtained for non-digested samples
are much higher that control, which indicates that chicken muscle doesn’t need
digestion to produce potentially bioavailable forms of iron. These results also showed
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that lyophilization of raw CMS caused a significant loss in total dialyzable iron and
dialyzable ferrous. This implied that the factor(s) responsible for production of
dialyzable iron, which does not need digestion, is sensitive to lyophilization. This
result is in contradiction with one obtained by Huh et al. (Huh et al. 2005), who
concluded that digestion of lyophilized fish muscle did not affect its ability to produce
dialyzable iron. The loss in production of dialyzable iron for non-digested sample
could be attributed to the 32% loss of sulfhydryls and 15% loss of histidine, if there
are any low molecular weight peptides containing these amino acids are present in the
raw chicken, as it is shown that low molecular weight peptides containing these amino
acids have ability to chelate iron (Hamed et al. 1983; Mulvihill and Morrissey, 1998;
Swain et al. 2002).

Table 3 shows the values for total soluble iron and total dialyzable iron produced by
digested raw chicken sample for refrigerated, frozen and lyophilized treatments.
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SAMPLE

Total Soluble iron in
µg

Total Dialyzable iron in
µg

Control

131.3 ± 9.67 a

6.5 ± 0.93 d

Refrigerated

121.3 ± 1.49 a

74.1 ± 3.21 e

Frozen

114.4 ± 2.64 b

70.4 ± 2.01 e

Lyophilized

88.7 ± 5.11 c

24.5 ± 1.73 f

Table IV.E.3: Total soluble iron and total dialyzable iron produced by digested
control and raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ±
SD of total soluble and total dialyzable iron [Fe (II) + Fe (III)] in µg for total 6
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of samples has been subtracted from all the values.
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Figure IV.E.3: Production of total soluble iron and total dialyzable iron by digested
control and raw refrigerated, frozen and lyophilized chicken muscle samples.
Graphical representation of the data from table 3. TSI: Total Soluble Iron; TDI: Total
Dialyzable Iron.

Figure 3, shows that the total soluble iron and total dialyzable iron produced by
control and raw refrigerated, frozen and lyophilized chicken muscle sample (CMS).
The total soluble iron produced by refrigerated raw CMS is not significantly different
from frozen raw and CMS, which implies that freezing does not have any effect on
chicken muscle’s ability to keep iron soluble under gastric conditions. But, the total
soluble iron for lyophilized raw CMS is significantly different from that of
refrigerated and frozen CMS (p<0.05), which indicated that lyophilization affects
production of total soluble iron by raw CMS. This might be due to the structureconformational change in the protein structure caused by lyophilization. Total
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dialyzable iron produced by refrigerated raw and frozen raw CMS is not significantly
different from each other (p>0.05), which demonstrated that freezing does not affect
digested chicken muscle’s ability to chelate iron and carry it through a 6000 – 8000
Da dialysis membrane. But, there was ~65% drop in total dialyzable iron produced by
lyophilized raw CMS when compared with refrigerated and frozen raw CMS, which
implies that lyophilization has a major effect on chicken muscle’s ability to chelate
iron and carry it through 6000 – 8000 Da membrane. This might be because of
polymerization of proteins, which might have resulted in loss of sulfhydryl (-SH)
groups or oxidation of –SH groups during lyophilization. Also the total dialyzable
iron produced after digestion of raw CMS is much higher that non-digested raw CMS.
This implies that chicken muscle does not need digestion to produce potentially
bioavailable iron but digestion enhances its production significantly.

Table 4 shows the values for total dialyzable iron and dialyzable ferrous iron
produced by digested raw chicken sample for refrigerated, frozen and lyophilized
treatments.
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SAMPLE

Total Dialyzable iron in
µg

Dialyzable Ferrous Iron in
µg

Control

6.5 ± 0.93 a

2.8 ± 0.34 d

Refrigerated

74.1 ± 3.21 b

41.3 ± 2.04 e

Frozen

70.4 ± 2.01 b

40.9 ± 3.19 e

Lyophilized

24.5 ± 1.73 c

7.4 ± 1.38 a

Table IV.E.4: Total dialyzable iron and dialyzable ferrous iron produced by digested
control and raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ±
SD of total dialyzable iron [Fe (II) + Fe (III)] and dialyzable ferrous iron in µg for
total 6 pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of samples has been subtracted from all the values.
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Figure IV.E.4: Production of total dialyzable iron and dialyzable ferrous iron by
digested control and raw refrigerated, frozen and lyophilized chicken muscle samples.
Graphical representation of the data from table 4. TDI: Total Dialyzable Iron; DFI:
Dialyzable ferrous iron.

The total dialyzable iron and dialyzable ferrous iron produced by digested control and
raw refrigerated, frozen and lyophilized CMS is shown in figure 4. Total dialyzable
iron and dialyzable ferrous iron produced by refrigerated raw and frozen raw CMS is
not significantly different from each other (p>0.05), which implies that freezing
chicken muscle did not impair any change in raw chicken’s ability to produce
dialyzable ferrous iron and total dialyzable iron. But there was a drastic ~85% drop in
dialyzable ferrous iron for lyophilized raw CMS as compared with refrigerated and
frozen raw CMS, which indicated that lyophilization process almost destroyed the
factor responsible for producing potentially bioavailable form of iron. It’s shown in
the literature that sulfhydryl have ability to convert ferric [Fe (III)] form of iron to
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ferrous form [Fe (II)], and the drop in dialyzable ferrous iron can be correlated with
loss of sulfhydryl (-SH) groups.

Table 5 shows the values for total ferrous iron and dialyzable ferrous iron produced
by digested raw chicken sample for refrigerated, frozen and lyophilized treatments.
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SAMPLE

Total Ferrous Iron in
µg

Dialyzable Ferrous Iron in
µg

Control

14.7 ± 0.85 a

2.8 ± 0.34 d

Refrigerated

76.1 ± 2.13 b

41.3 ± 2.04 e

Frozen

74.0± 1.51 b

40.9 ± 3.19 e

Lyophilized

23.2 ± 1.92 c

7.4 ± 1.38 f

Table IV.E.5: Total ferrous iron and dialyzable ferrous iron produced by digested
control and raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ±
SD of total ferrous iron and dialyzable ferrous iron in µg for total 6 pancreatin
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05
or 95% confidence. Endogenous iron produced by the same amount of samples has
been subtracted from all the values.

60

TFI
DFI
b

80

b

70

micro g of Iron

60
50

e

e

40
30

c

20

a
f

10

d
0

C on

tro l
R

e
e f r ig

ra te

MS
d C

F ro z

MS
en C

ph
L yo

i li e d

CM

S

S a m p le T re a tm e n t

Figure IV.E.5: Production of total ferrous iron and dialyzable ferrous iron by digested
control and raw refrigerated, frozen and lyophilized chicken muscle samples.
Graphical representation of the data from table 5. TFI: Total Ferrous Iron; DFI:
Dialyzable ferrous iron.

Figure 5, shows that total ferrous iron and dialyzable ferrous iron produced by
digested control and raw refrigerated, raw and frozen CMS. Dialyzable ferrous iron is
already discussed in figure 5. The total ferrous iron produced by refrigerated and
frozen raw CMS is not significantly different from each other, which again suggest
that freezing does not impair any change in chicken muscle’s ability convert ferric [Fe
(III)] form to ferrous [Fe (II)] form of the iron. But, similar to dialyzable ferrous iron,
there is ~73% drop in total ferrous iron for lyophilized raw CMS as compared with
refrigerated and frozen raw CMS, which indicated that lyophilization affected
conversion of ferric form to ferrous form of iron. This may be attributed to the loss of
sulfhydryl group caused by lyophilization, as sulfhydryl groups have ability to convert
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ferric form to ferrous form. This indicated that –SH groups may play important role in
conversion of ferric form of iron to ferrous form, as there is very strong correlation
between the drops of –SH content and drop in total and dialyzable ferrous iron.

Table 6 shows the values for total dialyzable iron and dialyzable ferrous iron
produced due to digestion (Digested – Non-digested) by raw chicken sample for
refrigerated, frozen and lyophilized treatments.
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SAMPLE

Total Dialyzable iron in
µg

Dialyzable Ferrous Iron in
µg

Control

3.1 ± 0.93 a

0.7 ± 0.34 d

Refrigerated

36.0 ± 3.21 b

24.1 ± 2.04 e

Frozen

36.1 ± 2.01 b

25.7 ± 3.19 e

Lyophilized

5.1 ± 1.73 c

3.6 ± 1.38 a

Table IV.E.6: Total dialyzable iron and dialyzable ferrous iron produced due to
digestion (Digested – Non-digested) by control and raw refrigerated, frozen and
lyophilized chicken muscle samples. Mean ± SD of total dialyzable iron [Fe (II) + Fe
(III)] and dialyzable ferrous iron produced due to digestion in µg for total 6 pancreatin
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05
or 95% confidence. Endogenous iron produced by the same amount of samples has
been subtracted from all the values.
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Figure IV.E.6: Production of total dialyzable iron and dialyzable ferrous iron due to
digestion (Digested – Non-digested) by control and raw refrigerated, frozen and
lyophilized chicken muscle samples. Graphical representation of the data from table
6. TDI: Total Dialyzable Iron; DFI: Dialyzable ferrous iron.

Figure 6 shows the effect of digestion only (non-digested iron values are subtracted
from digested iron values for corresponding chicken muscle sample) on production of
dialyzable iron and non-dialyzable iron by control, refrigerated, frozen and
lyophilized raw chicken muscle. Refrigerated and frozen chicken muscle produced
about 12 times as much dialyzable iron as that of control, whereas lyophilized chicken
produced 1.5 times dialyzable iron as that of control. Also, the dialyzable ferrous iron
produced by refrigerated and frozen chicken was 32 times as much as that of control
and lyophilized chicken produced about 5 times dialyzable ferrous iron as that of
control.
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These results showed that almost 70% of total dialyzable iron produced during
digestion is ferrous refrigerated, frozen and lyophilized chicken muscle sample. There
is huge drop in total dialyzable and dialyzable ferrous iron produced by lyophilized
chicken as compared to refrigerated and frozen chicken. This implies that the factor
responsible for producing dialyzable forms of iron was affected significantly during
lyophilization, but it was not destroyed completely as the values are higher than
control. This can be attributed to the loss of –SH and histidine during lyophilization
process. These results clearly showed that lyophilization has significant effect on
chicken muscle’s ability to produce potentially bioavailable forms of iron. This might
be due to the structure-conformational changes in chicken muscle protein because of
loss of water during lyophilization process.

Table 7 shows the values for total soluble protein and total dialyzable protein
produced by digested raw refrigerated, frozen and cooked chicken muscle sample.
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SAMPLE

Total Soluble Protein in
mg

Total Dialyzable Protein in
mg

Refrigerated

380.5 ± 5.32 a

295.3 ± 10.12 c

Frozen

384.8 ± 7.88 a

306.4 ± 11.81 bc

Lyophilized

320.5 ± 4.11 b

223.4 ± 12.48 d

Table IV.E.7: Total soluble protein and total dialyzable protein values for digested
raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ± SD of total
soluble protein and total dialyzable protein in mg for total 6 pancreatin digestions (n =
6). Different subscripts indicates difference using One Way ANOVA test for α = 0.05
or 95% confidence.
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Figure IV.E.7: Production of total soluble protein and total dialyzable protein by raw
refrigerated, frozen and lyophilized chicken muscle samples. Graphical representation
of the data from table 6. TSP: Total Soluble Protein; TDP: Total Dialyzable Protein.

The production of total soluble protein and total dialyzable protein by digested raw
refrigerated, frozen and lyophilized CMS is shown in figure 7. There is no significant
difference between refrigerated and frozen raw CMS on production of total soluble
protein and total dialyzable protein. However, lyophilization caused small but
significant change in production of dialyzable protein. However, lyophilization
caused ~15% and ~25% drop in total soluble protein and total dialyzable protein,
respectively as compared to refrigerated and frozen CMS. This indicates that
lyophilization affects digestibility of chicken muscle. This may be due to the
polymerization of chicken muscle protein during lyophilization, which made it
difficult for the enzymes to break it down into small peptides and this may be one of
the factor responsible for producing different amounts of potentially bioavailable iron.
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IV.F. Conclusions:

After this study, following conclusions can be made:

 Chicken muscle does not need digestion to produce potentially bioavailable
forms of iron. However digestion enhances its production significantly.

 Freezing does not affect chicken muscle’s ability to produce potentially
bioavailable forms of iron.

 Lyophilization causes significant loss in total sulfhydryl and histidine content,
which may be due to the polymerization of muscle proteins during
lyophilization.

 Lyophilization decreases chicken muscle’s ability to produce potentially
bioavailable forms of iron and this is well correlated with decrease in –SH and
histidine content.

 The digestibility of chicken muscle affected significantly after lyophilization.
This may be due to the polymerization of chicken muscle protein, which made
it difficult for the enzymes to break it down in smaller peptides.
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CHAPTER V
EFFECT OF COOKING ON IRON BIOAVAILABILITY OF CHICKEN
MUSCLE

V.A. Introduction:

From preliminary work, it is clear that lyophilization has a significant effect on
sulfhydryl content and ability of chicken muscle to produce potentially bioavailable
forms of iron. However, freezing chicken muscle slurry did not cause any significant
effect on sulfhydryl content and production on potentially bioavailable species of iron.
As we want to maintain the uniformity of the sample throughout the study, chicken
muscle slurry can be frozen as it does not affect its ability to produce potentially
bioavailable forms of iron. It will be interesting to cook the chicken muscle sample at
different temperatures and obtain the values for amino acid content and dialyzable
iron and to find the correlation between them.

This chapter will focus on effect of cooking chicken muscle at four different
temperatures. Chicken muscle slurry was cooked at 130oF, 150oF, 165oF and 195oF in
a boiling water bath, cooled to room temperature, poured into 1 pound plastic
container and frozen at -40oC in a chest freezer. These samples were thawed overnight
in the refrigerated and subjected to pepsin and pancreatin digestion and analyzed for
dialyzable iron values. The dialyzable iron values will be compared with amino acid
content to see if there is any correlation between them. Detailed procedure for sample
preparation and analysis is described in Chapter III.
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V.B. Materials and Methods:

V.B.1. Chemicals:

As discussed in Chapter III except for freshly prepared solutions described below:

Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO,
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w).

Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO,
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of
1:50 (w/w)

PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the
concentration of 50mg/ml, were dissolved in 50 ml of this buffer.
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V.B.2. Sample Preparation and Digestion Protocol:

As described in chapter III, except where specifically noted.

V.C. General Analysis Methods:

As described in chapter III, except where specifically noted.

V.D. Controls:

As described in chapter III, except where specifically noted.

V.E. Results and Discussion

Table 1 shows the values for total sulfhydryl and histidine content of raw and cooked
(130oF, 150oF, 165oF and 195oF) chicken muscle sample (CMS).
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Sample Treatment

Sulfhydryl content µM/g
protein sample

Histidine content µM/g
protein sample

Raw Chicken Muscle
Sample

124.8 ± 6.58 a

162.0 ± 1.99 f

Cooked (130oF)
Chicken Muscle Sample

73.0 ± 1.89 b

129.0 ± 1.57 a

Cooked (150oF)
Chicken Muscle Sample

55.5 ± 0.97 c

124.0 ± 0.32 a

Cooked (165oF)
Chicken Muscle Sample

31.5 ± 2.65 d

101.6 ± 11.27 g

Cooked (195oF)
Chicken Muscle Sample

27.3 ± 0.93 e

83.2 ± 0.65 h

Table V.E.1: Total sulfhydryl and histidine content for raw and cooked (130oF, 150oF,
165oF and 195oF) chicken muscle samples in µM/g protein. Mean ± SD of total
sulfhydryl and histidine content of 6 samples (n = 6). Different subscripts indicates
difference using One Way ANOVA test for α = 0.05 or 95% confidence.
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Figure V.E.1: Total sulfhydryl and histidine content of raw and cooked (130oF, 150oF,
165oF and 195oF) chicken muscle samples. Graphical representation of the data from
table 1.

The effect of heating on the total sulfhydryl (-SH) and histidine content of raw and
cooked CMS is shown in figure 1. There was a significant ~40% drop in total –SH
and ~20% drop in histidine content was observed when the chicken muscle was
heated to 130oF. When the chicken muscle was heated to 150oF, the total –SH and
histidine content dropped further, by ~55% and ~23% respectively, as compared to
raw. Heating chicken muscle to 165oF resulted in further reduction of 75% in total –
SH content and ~37% in histidine content as compared to raw CMS. Only 20% of
original –SH content was left i.e. ~80% was destroyed, when the cooking temperature
of 195oF was used. Also, the histidine contend was dropped to half of the original
histidine content after heating the chicken muscle to 195oF.
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These result indicated that sulfhydryls are very sensitive to heat. Heating chicken
muscle at 130oF and 150oF caused a significant reduction in total –SH content. These
results are in contradiction with those mentioned by Hoffman and Hamm (Hoffman
and Hamm, 1978), who measured the accessible –SH content and stated that heating
myofibrils from 86oF to 158oF causes increase in accessible –SH group because of
unfolding of protein molecules. The increase in cooking temperature of chicken
muscle from 165oF to 195oF caused further destruction of –SH content. These results
are consistent with those obtained by Hoffman and Hamm (Hoffman and Hamm,
1978), which mentioned that heating chicken muscle protein above 160oF results in
the loss of –SH content. The results obtained for histidine content showed that
histidine is also heat sensitive, but not as much as that of –SH. There is no data to
compare the histidine results in literature as no one mentioned effect of heat on
histidine content.

Table 2, gives the values for total soluble iron and total dialyzable iron produced by
digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle
samples.
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Sample

Total Soluble Iron in
µg

Total Dialyzable iron
in µg

Mean ± SD
[Fe (II) + Fe (III)]
Control

131.3 ± 9.67 a

6.5 ± 0.93 g

Raw Chicken

114.4 ± 2.64 b

70.4 ± 2.01 f

Cooked (130oF) CMS

98.8 ± 2.49 c

55.0 ± 2.16 h

Cooked (150oF) CMS

89.8 ± 1.92 d

43.4 ± 1.14 i

Cooked (165oF) CMS

85.1 ± 1.56 e

37.0 ± 0.99 j

Cooked (195oF) CMS

70.6 ± 5.04 f

9.5 ± 0.76 k

Table V.E.2: Total soluble iron and total dialyzable iron values for digested control,
raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ±
SD of total soluble and total dialyzable iron [Fe (II) + Fe (III)] in µg for total 6
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of samples has been subtracted from all the values.
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Figure V.E.2: Production of total soluble iron and total dialyzable iron by control, raw
and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Graphical
representation of the data from table 2. TSI: Total Soluble Iron; TDI: Total Dialyzable
Iron.

The total soluble iron and total dialyzable iron produced by raw and cooked chicken
muscle is shown in figure 2. Results showed that the total soluble iron produced by
raw chicken was only slightly less than the control. In case of cooked 131oF chicken
muscle, there was a significant ~25% drop in total soluble iron as compared to
control. The total soluble iron decreased further with the increase in cooking
temperature. There was ~41%, ~35% and ~46% drop in total soluble iron for cooked
150oF, 165oF and 195oF chicken muscle respectively, as compared to control. The
total dialyzable iron for raw chicken was 12 times higher than that of control, which
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showed chicken muscle’s ability to promote iron bioavailability. Cooking caused drop
in production of total dialyzable. Total dialyzable iron is further discussed in figure 3.
These results indicated that cooking chicken muscle results in the loss of its ability to
keep iron in the soluble form, which is a primary requirement to make iron potentially
bioavailable. This may be due to the ability of soluble high molecular weight fraction
(HMWF), which chelates iron and is then precipitated by TCA. This may be because
the HMWF might contain histidine and cysteine containing peptides, as it is
previously shown that they have ability to bind iron and keep it in the soluble form
(Mulvihill and Morrissey, 1997; Seth and Mahoney, 2000; Swain et al. 2001) and
figure 1 shows that histidine and –SH content drops with increase in cooking
temperature. In conclusion, heating chicken muscle affects its ability to keep iron in
soluble form.

Table 3 gives the values for total dialyzable iron and dialyzable ferrous iron produced
by digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle
samples.
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Sample

Total Dialyzable Iron
in µg

Dialyzable Ferrous Iron
in µg

Mean ± SD

Control

6.5 ± 0.93 a

2.8 ± 0.34 g

Raw Chicken

70.4 ± 2.01 b

49.9 ± 3.19 c

Cooked (130oF) CMS

55.0 ± 2.16 c

36.4 ± 1.43 e

Cooked (150oF) CMS

43.4 ± 1.14 d

16.6 ± 0.92 h

Cooked (165oF) CMS

37.0 ± 0.99 e

13.4 ± 0.45 i

Cooked (195oF) CMS

9.5 ± 0.76 f

5.5 ± 0.32 a

Table V.E.3: Total dialyzable iron and dialyzable ferrous iron values for digested
control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples.
Mean ± SD of total dialyzable iron and dialyzable ferrous iron in µg for total 6
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of samples has been subtracted from all the values.
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Figure V.E.3: Production of total dialyzable iron and dialyzable ferrous iron by
control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples.
Graphical representation of the data from table 3. TDI: Total Dialyzable Iron; DFI:
Dialyzable Ferrous Iron.

Total dialyzable iron and dialyzable ferrous iron produced by raw and cooked chicken
muscle samples is shown in figure 3. Raw chicken produced about 11 times as much
total dialyzable iron and 17 times dialyzable ferrous iron as that of control, which
clearly shows that chicken muscle is very good enhancer of iron bioavailability.
Heating chicken muscle to 130oF caused ~40% drop in total dialyzable iron and ~26%
drop in dialyzable ferrous iron, as compared to raw chicken sample. When the
cooking temperature was increased to 150oF, this resulted in 50% drop in total
dialyzable iron and 60% drop in dialyzable iron as compared to raw chicken sample.
Further heating the sample to 165oF and 195oF caused a significant ~70% and ~77%
drop in total dialyzable iron respectively. The dialyzable ferrous iron decreased by
75% and 90%, when the samples were heated to 165oF and 195oF.

79

These results clearly show that heating chicken muscle has very strong effect on its
ability to produce potentially bioavailable forms of iron. The drop in total dialyzable
and dialyzable ferrous iron at 130oF shows that the factor(s) responsible for
production of potentially bioavailable forms of iron is very heat labile and gets
affected even if the sample is heated to 130oF. Also, the drop in total dialyzable and
dialyzable ferrous iron continues when further addition of heat. Figure 1 shows that
total sulfhydryl (-SH) and histidine content is also affected with increasing cooking
temperature. So there is a very strong correlation between the drops of –SH, histidine
and potentially bioavailable forms of iron. As mentioned in the literature –SH groups
have ability to reduce ferric form of iron to ferrous form, which is the most potentially
bioavailable form of iron (Taylor et al. 1986; Kirwan et al. 1993; Mulvihill and
Morrissey, 1998; Mulvihill et al. 1998). Also histidine containing peptides have
ability to chelate iron (Seth and Mahoney, 2000). In conclusion, these results indicate
that sulfhydryl and histidine containing peptides might be involved production of
potentially bioavailable forms of iron, as there is a very strong correlation between the
drops of –SH, histidine and iron values.

Table 4 gives the values for total ferrous iron and dialyzable ferrous iron produced by
digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle
samples.
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Sample

Total Ferrous Iron
in µg

Dialyzable Ferrous Iron
in µg

Mean ± SD

Control

14.7 ± 0.85 a

2.8 ± 0.34 g

Raw Chicken

90.0 ± 1.51 b

49.9 ± 3.19 d

Cooked (130oF) CMS

55.4 ± 1.63 c

36.4 ± 1.43 h

Cooked (150oF) CMS

46.1 ± 1.39 d

16.6 ± 0.92 a

Cooked (165oF) CMS

25.7 ± 1.52 e

13.4 ± 0.45 a

Cooked (195oF) CMS
20.3 ± 1.39 f
5.5 ± 0.317 i
Table V.E.4: Total ferrous iron and dialyzable ferrous iron values for digested control,
raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ±
SD of total ferrous iron and dialyzable ferrous iron in µg for total 6 pancreatin
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05
or 95% confidence. Endogenous iron produced by the same amount of samples has
been subtracted from all the values.
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Figure V.E.4: Production of total ferrous iron and dialyzable ferrous iron by control,
raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Graphical
representation of the data from table 4. TFI: Total Ferrous Iron; DFI: Dialyzable
Ferrous Iron.

The total ferrous iron and dialyzable ferrous iron produced by digested control, raw
and cooked chicken muscle samples is shown in figure 4. Raw chicken produced
about six times as much total ferrous iron as that of control and 17 times dialyzable
ferrous iron as that of control, which clearly showed chicken muscle’s ability to
reduce ferric form of iron to ferrous form and make it potentially bioavailable.
Cooking the sample at 130oF resulted in ~38% drop in total ferrous iron and ~25%
loss in total dialyzable iron. Further cooking the sample at 150oF resulted in drop of
total ferrous iron to half and dialyzable ferrous iron to one third as compared to raw
chicken sample. Cooking temperatures of 165oF and 195oF resulted in collapse of
total ferrous iron by approximately 75%, as compared with raw chicken. The
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dialyzable ferrous iron dropped by 73% and 90% for cooked 165oF and 195oF chicken
muscle respectively, as compared to raw chicken muscle.
These results shows that cooking chicken even at 130oF results in the loss of
potentially bioavailable forms of iron, which implies that the meat factor(s) is heat
labile. The increase in cooking temperature from 130oF to 195oF results in significant
drop in production of potentially bioavailable forms of iron. Dialyzable ferrous iron
produced by cooked 195oF sample is higher than that of control, which implies that
heating chicken muscle at 195oF did not destroy the meat factor(s) completely. From
figure 1, it is clear that –SH and histidine content drops significantly and show that
similar trend as that of total ferrous iron and total dialyzable iron. It is well know that
–SH group has ability to reduce ferric form of iron to ferrous form (Taylor et al. 1986;
Kirwan et al. 1993; Mulvihill and Morrissey, 1998; Mulvihill et al. 1998) and
histidine containing peptides can chelate iron (Seth and Mahoney, 2000). So the loss
of chicken muscle’s ability to produce potentially bioavailable forms of iron is well
correlated with that of –SH and histidine content.
In conclusion heating chicken muscle results in loss of its ability to produced
potentially bioavailable forms of iron and –SH and histidine containing peptides
might be responsible for ‘meat factor’.

Table 5 gives the values for total dialyzable iron and dialyzable ferrous iron produced
by non-digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken
muscle samples.

83

Sample

Total Dialyzable Iron
in µg

Dialyzable Ferrous Iron
in µg

Mean ± SD

Control

2.9 ± 0.44 a

2.0 ± 0.46 a

Raw Chicken

34.2 ± 0.89 b

15.1 ± 0.90 g

Cooked (130oF) CMS

30.0 ± 1.70 c

20.9 ± 1.11 d

Cooked (150oF) CMS

20.5 ± 0.73 d

10.9 ± 0.65 h

Cooked (165oF) CMS

6.0 ± 1.18 e

2.0 ± 0.85 a

Cooked (195oF) CMS

4.0 ± 0.39 f

2.5 ± 0.39 a

Table V.E.5: Total dialyzable iron and dialyzable ferrous iron values for non-digested
control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples.
Mean ± SD of total dialyzable iron and dialyzable ferrous iron in µg for total 6
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of samples has been subtracted from all the values.
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Figure V.E.5: Production of total dialyzable iron and dialyzable ferrous iron by nondigested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle
samples. Graphical representation of the data from table 5. TDI: Total Dialyzable
Iron; DFI: Dialyzable Ferrous Iron.

The total dialyzable iron and dialyzable ferrous iron produced by non-digested raw
and cooked sample is shown in figure 5. Non-digested raw chicken produced about 12
times total dialyzable iron and 7 times dialyzable ferrous iron as that of control. The
total dialyzable iron produced by cooked 130oF chicken sample dropped slightly by
insignificant 10% as compared to control. The dialyzable ferrous iron increased by
~30% as compared with raw chicken, which may be attributed to the unfolding of
protein molecules and exposure of accessible –SH groups to the iron. There was drop
in both total dialyzable iron and dialyzable ferrous iron by approximately 40% and
33%, respectively for cooked 150oF chicken sample as compared with raw chicken.
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When the sample was cooked at 165oF and 195oF, the total dialyzable iron collapsed
by 82% and 88% respectively, as compared with raw chicken. The total ferrous iron
was dropped by a very significant amount and was similar to that produced by
control.
These results show that chicken muscle does not need digestion to produce potentially
bioavailable forms of iron. This implies that some of the ‘meat factor(s)’ is present in
raw meat, which does not need digestion to produce potentially bioavailable forms of
iron. However, from figure 3 it’s also clear that digestion helps to produce more
potentially bioavailable iron, which implies that some of the ‘meat factor(s)’ is
produced during digestion. The drop in total dialyzable iron and dialyzable ferrous
iron for cooked samples indicates that the ‘meat factor(s)’ present in raw meat is very
heat sensitive. The dialyzable ferrous iron for cooked 165oF and 195oF sample
dropped to the level which is not significantly different from control.
This implies that the ‘meat factor(s)’ present in raw meat, which does not need
digestion to produce potentially bioavailable forms of iron, was destroyed completely
when chicken was cooked at 165oF. However, from figure IV.E.3 it is clear that the
total dialyzable iron and dialyzable ferrous iron produced by cooked 165oF and 195oF
chicken sample is much higher than control. This implies that most of the ‘meat
factor(s)’ for cooked 165oF and 195oF chicken sample was produced during digestion.
In conclusion, the ‘meat factor’ present in raw meat, which does not need digestion to
produce potentially bioavailable forms of iron, was destroyed completely when
chicken was cooked at 165oF.
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Table 6 gives the values for total dialyzable iron and dialyzable ferrous iron produced
because of digestion (non-digested iron values are subtracted from the digested iron
values for the corresponding sample) by control, raw and cooked (130oF, 150oF,
165oF and 195oF) chicken muscle samples.

Sample

Total Dialyzable Iron
in µg

Dialyzable Ferrous Iron
in µg

Mean ± SD

Control

3.6 ± 0.93 a

0.7 ± 0.34 f

Raw Chicken

36.1 ± 2.01 b

34.7 ± 3.19 b

Cooked (130oF) CMS

25.0 ± 2.16 c

15.4 ± 1.43 g

Cooked (150oF) CMS

22.8 ± 1.14 c

5.6 ± 0.92 h

Cooked (165oF) CMS

31.0 ± 0.99 d

11.3 ± 0.45 i

Cooked (195oF) CMS

5.4 ± 0.76 e

2.9 ± 0.32 a

Table V.E.6: Total dialyzable iron and dialyzable ferrous iron produced due to
digestion (digested iron – non-digested iron values) of control, raw and cooked
(130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ± SD of total
dialyzable iron and dialyzable ferrous iron in µg for total 6 pancreatin digestions (n =
6). The total amount of iron used for each pancreatin digestion is 279 µg. Different
subscripts indicates difference using One Way ANOVA test for α = 0.05 or 95%
confidence. Endogenous iron produced by the same amount of samples has been
subtracted from all the values.
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Figure V.E.6: Production of total dialyzable iron and dialyzable ferrous iron due to
digestion (digested iron – non-digested iron values) of control, raw and cooked
(130oF, 150oF, 165oF and 195oF) chicken muscle samples. Graphical representation of
the data from table 6. TDI: Total Dialyzable Iron; DFI: Dialyzable Ferrous Iron.

The total dialyzable iron and dialyzable ferrous iron produced because of digestion
(non-digested iron values are subtracted from the digested iron values for the
corresponding sample) is shown in fig 6. Raw and cooked (130oF) chicken samples
produced about 10 times and 7 times as much dialyzable iron as that of control,
respectively, whereas cooked 150oF and 165oF chicken samples produced about 6
times and 8 times total dialyzable iron as that of control, respectively. The total
dialyzable iron produced by cooked 195oF chicken sample was slightly higher than
control. In case of dialyzable ferrous iron, almost 100% dialyzable iron produced is
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ferrous for raw chicken sample. But, the percentage of dialyzable ferrous iron
produced by cooked samples decreases with temperature, except for cooked 165oF.
These results clearly showed that digestion of chicken muscle does produce
potentially bioavailable forms of iron and it’s in contradiction with the results
obtained by Huh et al. (Huh et al. 2005) who suggested that digestion did not produce
potentially bioavailable forms of iron. Also, the drop in production of total dialyzable
and dialyzable ferrous iron with temperature is well correlated with the drop in –SH
and histidine content for corresponding samples, which are suggested to be
responsible for ‘meat factor’.

Table 7 gives the values for total soluble protein and total dialyzable protein produced
by lyophilized raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle
samples.
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Sample

Total Soluble Protein
in mg

Total Dialyzable Protein
in mg

Mean ± SD

Control

-

-

Raw Chicken

384.8 ± 7.88 a

306.4 ± 11.81 d

Cooked (130oF) CMS

364.0 ± 8.67 b

235.8± 8.24 e

Cooked (150oF) CMS

340.7 ± 3.56 c

237.5 ± 8.46 e

Cooked (165oF) CMS

378.5 ± 10.29 ab

265.0± 18.49 e

Cooked (195oF) CMS

386.3 ± 3.59 a

322.5 ± 21.27 d

Table V.E.7: Total soluble protein and total dialyzable protein values for digested raw
and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ± SD of
total soluble protein and total dialyzable protein in mg for total 6 pancreatin
digestions (n = 6). The total amount of protein used for each pancreatin digestion is
400 mg. Different subscripts indicates difference using One Way ANOVA test for α =
0.05 or 95% confidence.
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Figure V.E.7: Production of total soluble protein and total dialyzable protein by
digested raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples.
Graphical representation of the data from table 7. TSP: Total Soluble Protein; TDP:
Total Dialyzable Protein.

The production of total soluble protein and total dialyzable protein by digested raw
and cooked chicken muscle samples is shown in figure 7. Even if there is slight
variation in total soluble protein produced by raw and cooked samples, there is no
significant difference between them. Total soluble protein produced by raw and
cooked chicken muscle samples are not significantly different from each other, which
suggests that digestion of chicken muscle was uniform and was not a factor
responsible for difference in the dialyzable iron produced. Total dialyzable protein
produced by raw chicken muscle is higher than cooked 130oF, 150oF and 165oF and it
is not significantly different from that of cooked 195oF chicken sample. These results
suggest that cooking temperature plays important role in digestibility of chicken
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muscle samples. At 195oF, the proteins may be denatured well enough to get digested;
whereas at lower cooking temperature, the digestibility might have affected because
of polymerization of proteins.

V.F. Conclusions:

After this study, following conclusion can be made:

 Chicken muscle does not need digestion to produce potentially bioavailable
forms of iron. But digestion increases the amount of potentially bioavailable
forms of iron significantly.

 Heating causes progressive decrease in production of dialyzable iron by both
digested and non-digested chicken muscle samples.

 The total dialyzable iron, which is an important marker of potentially
bioavailable forms of iron in in-vitro study, dropped significantly with
increase in cooking temperature and this drop is well correlated with the drop
in sulfhydryl and histidine content. This suggests that sulfhydryl and histidine
play an important role in ‘meat factor’.

 The factor(s) responsible to convert ferric from of iron to ferrous is very heat
labile. This can be correlated with the drop in total -SH content as –SH groups
have ability to reduce ferric iron to ferrous form.
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CHAPTER VI
PRODUCTION OF DIALYZABLE IRON BY LYOPHILIZED RAW AND
COOKED SAMPLES
VI.A. Introduction:

Literature survey suggests that effect of cooking chicken on production of potentially
bioavailable forms of iron has not been given much attention. Cysteine containing
peptides of meat, e.g. glutathione (Taylor et al. 1986) and sulfhydryl (-SH) and
disulphide groups in meat (Hoffman and Hamm 1978), have been suggested to be
responsible for ‘meat factor’, but the effect of cooking on these factors has not been
given much emphasis. It is well known that sulfhydryls are heat labile and heating
temperature plays important role in sulfhydryl degradation. Literature review
indicates no such study where the effect on sulfhydryl and histidine content under
cooking conditions is measured. We selected heating temperature as 165oF and 195oF.
165oF is minimum temperature to kill microbes and 195oF is used for further heating
reference temperature.

Chicken muscle slurry was heated at 165 and 195oF in a boiling water bath, cooled to
room temperature and 100g of raw and heated slurry was poured in 1 pound
containers to the thickness of 1 cm. These samples were frozen to -40oC and
lyophilized in a commercial lyophilizer. After lyophilization, the sample were stored
at -15oC and used as required for the experiments. The amount of dialyzable iron
formed, -SH and histidine content of each sample was analyzed using methods
described in Chapter III and the results were compared with raw chicken values.
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VI.B. Materials and Methods:

VI.B.1. Chemicals:

As discussed in Chapter III except for freshly prepared solutions below:

Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO,
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w).

Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO,
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of
1:50 (w/w)

PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the
concentration of 50mg/ml, were dissolved in 50 ml of this buffer.

VI.B.2. Sample preparation:

As described in chapter III, except where specifically noted.
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VI.C. Analysis:

As discussed in chapter III, except where specifically noted.

VI.D. Controls:

As described in chapter III, except where specifically noted.

VI.E. Results and Discussion

This section presents the amino acid, iron and protein values of lyophilized raw and
cooked (165oF and 195oF) samples in comparison with control. The endogenous
control values were subtracted from each digested sample to obtain the values shown
in this section.

Table 1 gives the values for total sulfhydryl and histidine content of lyophilized raw
and cooked (165oF and 195oF) chicken muscle samples (CMS).
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Sample

Sulfhydryl content µM/g
protein sample

Histidine content µM/g
protein sample

Lyophilized Raw
CMS

89.7±3.78 a

136.3±2.03 d

Lyophilized Cooked (165oF)
CMS

64.0±3.94 b

99.7±3.72 e

Lyophilized Cooked (195oF)
CMS

40.2±2.17 c

82.6±2.66 f

Table VI.E.1: Total sulfhydryl and histidine content for lyophilized raw and cooked
(165oF and 195oF) chicken muscle samples in µM/g protein. Mean ± SD of total
sulfhydryl and histidine content of 6 samples (n = 6). Different subscripts indicates
difference using One Way ANOVA test for α = 0.05 or 95% confidence.
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Figure VI.E.1: Total sulfhydryl and histidine content of lyophilized raw and cooked
(165oF and 195oF) chicken muscle samples. Graphical representation of the data from
table 1.

Figure 1, shows the sulfhydryl content for lyophilized raw and cooked samples (165oF
and 195oF) is significantly different from each other (p<0.05). Sulfhydryl content of
lyophilized cooked 165oF and 195oF CMS dropped by ~30% and ~55%, as compared
with lyophilized raw samples respectively. This implies that sulfhydryls are heat
labile and were degraded at 165oF and the degradation continued till 195oF. The effect
of further heating is unknown to us as 195oF was highest temperature of heating for
our study. The histidine values were also dropped by ~30 % and ~40% for lyophilized
cooked 165oF and 195oF CMS respectively, when compared with raw CMS. The
effect of heating on histidine is not mentioned in anywhere in literature. This implies
that histidine is also heat labile and may be a factor responsible for drop in dialyzable
total iron.
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Table 2, gives the values for total soluble iron and total dialyzable iron produced by
digested control, lyophilized raw and cooked (165oF and 195oF) chicken muscle
samples.

Sample

Total soluble iron in
µg

Total dialyzable iron in
µg

Mean ± SD

Control

131.3 ± 9.67 a

6.5 ± 0.93 d

Raw Chicken

88.7 ± 5.11 b

24.5 ± 1.73 e

Cooked (165oF) chicken

79.6 ± 6.87 b

21.7 ± 0.90 f

Cooked (195oF) chicken

64.1 ± 3.36 c

21.1 ± 1.27 f

Table VI.E.2: Total soluble iron and total dialyzable iron values for no protein
control, lyophilized raw and cooked (165oF and 195oF) chicken muscle samples.
Mean ± SD of total soluble and total dialyzable iron [Fe (II) + Fe (III)] in µg for total
6 pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of samples has been subtracted from all the values.

98

TSI
TDI
a
140

120

micro g of Iron

100

b
b

80

c
60

40

e

f

f

20

d
0
C o n tro l

R aw

C ooked 165 F

C ooked 195 F

S a m p le

Figure VI.E.2: Production of total soluble iron and total dialyzable iron by control,
lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. Graphical
representation of the data from table 2. TSI: Total Soluble Iron; TDI: Total Dialyzable
Iron.

Figure 2, indicates the total soluble iron produced by digested control and lyophilized
raw and cooked (165oF and 195oF) are significantly different (p<0.05). The total
soluble iron is dropped by ~32% in case of lyophilized raw, ~40% in case of cooked
(165oF) and ~50% in case of cooked (195oF) chicken muscle sample as compared to
control. This can be attributed to the high molecular weight fractions from chicken
muscle samples, which bind iron and then precipitated when TCA was added. This
suggests that the fraction which was not digested completely (high molecular weight
fraction) bound large amount of inorganic iron and it was precipitated by TCA. This
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may be due to heat induced

polymerization of proteins, which reduced the

digestibility of chicken. The total dialyzable iron values for lyophilized raw and
cooked (165oF and 195oF) are very distinct from control (p<0.05). The total
dialyzable iron produced by uncooked chicken is slightly higher than cooked CMS.
However, the total dialyzable iron produced by cooked 165oF and cooked 195oF CMS
is not significantly distinct from each other. This suggested that heating chicken from
165 to 195oF did not cause any further drop in total dialyzable iron, even though the
total sulfhydryl and histidines dropped. Total dialyzable iron is further discussed in
figure 3.

Table 3 gives the values for total dialyzable iron and dialyzable ferrous iron produced
by no protein control, lyophilized raw and cooked (165oF and 195oF) chicken muscle
samples.

100

Sample

Total dialyzable iron in
µg

Dialyzable ferrous iron
in µg

Mean ± SD

Control

6.5 ± 0.93 a

2.8 ± 0.34 c

Raw Chicken

24.5 ± 1.73 b

7.4 ± 1.38 d

Cooked (165oF) chicken

21.7 ± 0.90 b

7.2 ± 0.55 d

Cooked (195oF) chicken

21.1 ± 1.27 b

4.2 ± 1.50 c

Table VI.E.3: Total dialyzable iron and dialyzable ferrous iron values for digested
control, lyophilized raw and cooked (165oF and 195oF) chicken muscle samples.
Mean ± SD of total dialyzable [Fe (II) + Fe (III)] and dialyzable ferrous iron [Fe (II)]
in µg for total 6 pancreatin digestions (n = 6). The total amount of iron used for each
pancreatin digestion is 279 µg. Different subscripts indicates difference using One
Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced by the
same amount of sample has been subtracted from all the values.
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Figure VI.E.3: Production of total dialyzable iron and dialyzable ferrous iron by
digested control, lyophilized raw and cooked (165oF and 195oF) chicken muscle
samples. Graphical representation of the data from table 3. TDI: Total Dialyzable
Iron; DFI: Dialyzable ferrous Iron.

Figure 3, indicates the comparison between total dialyzable iron and dialyzable
ferrous iron produced by digested chicken muscle samples. Total dialyzable iron is ~4
times higher for lyophilized raw chicken muscle samples and ~3 times higher for
lyophilized cooked chicken muscle samples (165oF and 195oF). This proves the
previous findings that chicken muscle plays important role in production of
potentially bioavailable forms of iron (Hallberg, 1981; Berner and Miller, 1985;
Carpenter and Mahoney 1992; Seth and Mahoney, 2000). The total dialyzable iron
values for lyophilized cooked (165oF and 195oF) chicken muscle samples (CMS) are
not distinct from lyophilized raw CMS (p<0.05), which indicates that heating does not
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affects chicken muscle’s ability to produce potentially bioavailable forms of iron and
the factor(s) responsible for producing potentially bioavailable forms of iron is not
heat labile. Total dialyzable iron values for lyophilized cooked 165oF sample and
lyophilized cooked 195oF sample are not distinct (p>0.05) from each other. This
suggests that the factor(s) responsible for producing potentially bioavailable forms of
iron was degraded at 165oF, but heating it further to 195oF has no effect on these
factor(s). The findings for cooked samples are in consistent with those obtained by
Baech et al. (Baech et al. 2002), which suggested that increasing cooking temperature
of ham does not have any effect on iron bioavailability in-vivo. But the values for total
dialyzable iron for cooked samples are ~3 times higher than that of no protein control,
which implies that the factor(s) responsible for producing potentially bioavailable
forms of iron was affected slightly. Nearly 30% of the total dialyzable iron is ferrous
in case of lyophilized raw and cooked (165oF) CMS and nearly 20% of total
dialyzable iron is in ferrous form for cooked 195oF CMS. This indicates that only one
third of the total dialyzable iron was reduced to ferrous form, which is the most
potentially bioavailable form of iron and two third remained ferric. The marked
decrease in dialyzable ferrous iron for 195oF cooked sample may be correlated with
the ~55% drop in sulfhydryl content.

Overall, these results show that cooking does not have any prominent effect on
production of dialyzable iron species, except for dialyzable ferrous iron at 195oF,
despite the drop in –SH and histidine content.

Table 4 gives the values for total ferrous iron and dialyzable ferrous iron produced by
no protein control, lyophilized raw and cooked (165oF and 195oF) chicken muscle
samples.
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Sample

Total ferrous iron in
µg

Dialyzable ferrous iron in
µg

Mean ± SD

Control

14.7 ± 0.85 a

2.8 ± 0.34 c

Raw Chicken

23.2 ± 1.92 b

7.4 ± 1.38 d

Cooked (165oF) chicken

22.5 ± 1.54 b

7.2 ± 0.55 d

Cooked (195oF) chicken

20.7 ± 3.76 b

4.2 ± 1.50 c

Table VI.E.4: Total ferrous iron and dialyzable ferrous iron values for digested
control, lyophilized raw and cooked (165oF and 195oF) chicken muscle samples.
Mean ± SD of total ferrous [Fe (II)] and dialyzable ferrous iron [Fe (II)] in µg for total
6 pancreatin digestions (n = 6). The total amount of iron used for each pancreatin
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount
of sample has been subtracted from all the values.
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Figure VI.E.4: Production of total ferrous iron and dialyzable ferrous iron by control,
lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. Graphical
representation of the data from table 4. TFI: Total Ferrous Iron; DFI: Dialyzable
ferrous Iron.

Figure 4, shows that the total ferrous iron values obtained for digested lyophilized raw
and cooked samples (165oF and 195oF) are distinct from control (p<0.05). The total
ferrous iron values for chicken muscle samples are ~1.5 times higher than no protein
control, which suggests that chicken muscle produced higher amounts of total ferrous
iron as compared to no protein control. The total ferrous iron values for lyophilized
raw and cooked samples (165oF and 195oF) are not distinctly different from each
other when analyzed using one way ANOVA (p>0.05). This implies that the factor(s)
responsible for producing total ferrous iron is not destroyed by cooking. The values
for dialyzable ferrous iron for lyophilized raw and cooked (165oF) are distinct from
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no protein control (p<0.05), but for cooked (195oF) it is not distinct from control
(p>0.05). Lyophilized raw and cooked (165oF) sample produced ~2.5 times higher
values for most potentially bioavailable form of iron i.e. dialyzable ferrous iron as
compared to no-protein control. This suggests that the factor(s) responsible for
producing the most potentially bioavailable form of iron and carry it through 60008000 Da dialysis membrane was not destroyed after heating the chicken muscle
sample at 165oF. The dialyzable ferrous iron value for cooked (195oF) was much
lower than lyophilized raw and cooked (165oF) CMS, and slightly higher than no
protein control but not significantly different. This implies that the factor(s)
responsible for producing most potentially bioavailable form of iron is also heat labile
and destroyed completely at 195oF. The major component suggested to produce
ferrous iron in meat is sulfhydryl (Taylor et al. 1986; Kirwan et al. 1993; Mulvihill
and Morrissey, 1998; Mulvihill et al. 1998) and it is well know that sulfhydryl is heat
labile. So the drop in dialyzable ferrous iron could be attributed to the loss of
sulfhydryls during heating the chicken muscle sample.

Table 5 gives the values for total dialyzable iron for control, lyophilized raw and
cooked (165oF and 195oF) samples for iron only, iron pepsin and iron pepsin
pancreatin bile treatments.
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Sample

Control
(No Sample))
Raw
Sample
Cooked 165oF
Sample
Cooked 195oF
Sample

Iron Only
(No Enzymes)

Iron/Pep
(No PB)
Iron/Pep/PB
Mean ± SD
Total Dialyzable Iron [Fe(II) + Fe (III)] µg

2.9 ± 0.44 a

3.4 ± 0.52 a

6.0 ± 0.70 c

8.4 ± 0.49 b

19.4 ± 0.45 d

24.5 ± 1.73 f

6.0 ± 0.70 c

14.6 ± 0.75 e

21.7 ± 0.90 f

4.0± 0.95 a

15.5 ± 0.79 e

21.1 ± 1.27 f

Table VI.E.5: Total dialyzable iron produced by control, lyophilized raw and cooked
(165oF and 195oF) chicken muscle samples for Iron only (no enzymes), iron pepsin
(no pancreatin) and iron/pep/PB treatments. Mean ± SD of total dialyzable [Fe (II) +
Fe (III)] in µg for total 6 pancreatin digestions (n = 6). The total amount of iron used
for each pancreatin digestion is 279 µg. Different subscripts indicates difference using
One Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced
by the same amount of sample has been subtracted from all the values. Pep: Pepsin;
PB: Pancreatin Bile.
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Figure VI.E.5: Production of total dialyzable iron by control, lyophilized raw and
cooked (165oF and 195oF) chicken muscle samples for iron only (no enzymes), ironpep (no pancreatin) and iron pepsin pancreatin bile. Graphical representation of the
data from table 5.

Figure 5, indicates the effect of iron only (no enzymes), pepsin (no pancreatin) and
pepsin-pancreatin/bile digestion by lyophilized raw and cooked (165oF and 195oF)
CMS on production of total dialyzable iron and the values are significantly distinct
from each other (p<0.05). The iron only (no enzymes) treatment values for total
dialyzable iron produced by lyophilized raw and cooked (165oF and 195oF) chicken
muscle samples are slightly higher than control, which suggests that chicken muscle
does not need digestion to produce potentially bioavailable forms of iron. The values
obtained for total dialyzable iron for lyophilized raw and cooked (165oF and 195oF)
CMS show ~2.5 and ~3 times increase when pepsin (no pancreatin) and pepsin-
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pancreatin/bile were used for the digestion respectively, as compared with iron only
(no enzymes). This shows that chicken muscle do not need digestion to enhance iron
bioavailability but this also suggests that digestion further enhances production of
potentially bioavailable forms of iron by ~3 times. This result is in contradiction with
that obtained by Huh et al., which suggested that digestion is not necessary to produce
potentially bioavailable forms of iron in heated lyophilized fish muscle (Huh et al.
2005).

Table 6 gives the values for dialyzable ferrous iron for lyophilized raw and cooked
(165oF and 195oF) samples for iron only, iron pepsin and iron pepsin pancreatin bile
treatments.
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Sample

Control
(No Sample))
Raw
Sample
Cooked 165oF
Sample
Cooked 195oF
Sample

Iron Only
(No Enzymes)

Iron/Pep
(No PB)
Iron/Pep/PB
Mean ± SD
Dialyzable Ferrous Iron [Fe(II)] µg

2.0 ± 0.46 a

1.8 ± 0.50 a

2.8 ± 0.34 a

3.8 ± 0.96 b

8.4 ± 0.32 c

7.4 ± 1.38 c

3.2 ± 0.42 b

6.4 ± 1.08 c

7.2 ± 0.55 c

2.6 ± 0.42 a

3.2 ± 0.60 ab

4.2 ± 1.50 ab

Table VI.E.6: Dialyzable ferrous iron produced by control, lyophilized raw and
cooked (165oF and 195oF) chicken muscle samples for Iron only (no enzymes), iron
pepsin (no pancreatin) and iron/pep/PB. Mean ± SD of total dialyzable [Fe (II) + Fe
(III)] in µg for total 6 pancreatin digestions (n = 6). The total amount of iron used for
each pancreatin digestion is 279 µg. Different subscripts indicates difference using
One Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced
by the same amount of sample has been subtracted from all the values. Pep: Pepsin;
PB: Pancreatin Bile.
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Figure VI.E.6: Production of dialyzable ferrous iron by control, lyophilized raw and
cooked (165oF and 195oF) chicken muscle samples for iron only (no enzymes), ironpep (no pancreatin) and iron pepsin pancreatin bile. Graphical representation of the
data from table 6.

The effect of iron only (no enzymes), pepsin (no pancreatin) and pepsinpancreatin/bile digestion treatments on production of dialyzable ferrous iron by
lyophilized raw and cooked (165oF and 195oF) CMS is shown in figure 6. There was
no difference on dialyzable ferrous iron produced by lyophilized raw and cooked
165oF CMS for iron only treatment, but these values were ~1.5 times higher than
control. There was no significant difference between control and lyophilized cooked
195oF CMS, suggesting that the factor responsible for production of dialyzable
ferrous iron for iron only treatment was destroyed completely at 195oF. The
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dialyzable ferrous iron produced by raw chicken was five times higher than that of
control for iron pepsin treatment but heating chicken to 165oF did not cause any drop.
However when the chicken was heated to 195oF, a significant change was observed,
suggesting that the factor(s) responsible for production of dialyzable ferrous iron was
destroyed completely at 195oF, as the value is equal control. Also, these results
indicated that digestion is not necessary for production of dialyzable ferrous iron but
it helps to increase the amount of dialyzable ferrous iron significantly.

Table 7 gives the values for total dialyzable iron and dialyzable ferrous iron produced
because of digestion (non-digested iron values are subtracted from the digested iron
values for the corresponding sample) by control, lyophilized raw and cooked (165oF
and 195oF) chicken muscle samples.
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Sample

Total dialyzable iron in
µg

Dialyzable ferrous iron
in µg

Mean ± SD

Control

3.6 ± 0.93 a

0.7 ± 0.34 c

Raw Chicken

16.0 ± 1.73 b

3.6 ± 1.38 d

Cooked (165oF) chicken

15.6 ± 0.90 b

3.9 ± 0.55 d

Cooked (195oF) chicken

17.1 ± 1.27 b

1.6 ± 1.50 d

Table VI.E.7: Total dialyzable iron and dialyzable ferrous iron produced because of
digestion (digested iron – non-digested iron values) by control, lyophilized raw and
cooked (165oF and 195oF) chicken muscle samples. Mean ± SD of total dialyzable [Fe
(II) + Fe (III)] and dialyzable ferrous iron [Fe (II)] in µg for total 6 pancreatin
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05
or 95% confidence. Endogenous iron produced by the same amount of sample has
been subtracted from all the values.
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TDI
DFI

20

b

b

18

b
16

micro g of Iron

14
12
10
8
6

d

a

d

4
2

d

c

0
Control

Raw

Cooked 165F

Cooked 195F

Sample Treatment

Figure VI.E.7: Production of dialyzable ferrous iron by control, lyophilized raw and
cooked (165oF and 195oF) chicken muscle samples for iron only (no enzymes), ironpep (no pancreatin) and iron pepsin pancreatin bile. Graphical representation of the
data from table 7.

The total dialyzable iron and dialyzable ferrous iron produced because of digestion
(non-digested iron values are subtracted from digested iron values for the
corresponding sample) is shown in fig 7. The total dialyzable iron produced because
of digestion for raw and cooked chicken sample is ~5 times greater than that of
control. Also, the dialyzable ferrous iron produced because of digestion for raw and
cooked 165oF chicken sample is ~4 times higher than control, whereas for 195oF
sample, it is two times as much as that of control.
These results clearly showed that majority of total dialyzable iron are produced during
digestion. So digestion is very critical for production of potentially bioavailable forms
of iron. Also, it can be seen that, there is no effect of cooking on production of total
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dialyzable iron. As far as the dialyzable ferrous iron is concerned, there is not
significant difference for raw and cooked sample and heating does not have any effect
on it.
It can be concluded from these results that digestion is very necessary for production
of potentially bioavailable forms of iron and heating does not have any effect on
ability of chicken to produce potentially bioavailable forms of iron.

Table 8 gives the values for total soluble protein and total dialyzable protein produced
by lyophilized raw and cooked (165oF and 195oF) chicken muscle samples.
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Sample

Total soluble protein in
mg

Total dialyzable protein
in mg

Mean ± SD

Raw Chicken

320.5 ± 4.11 a

223.4 ± 12.48 d

Cooked (165oF) chicken

362.6 ± 10.92 b

260.7 ± 16.3 e

Cooked (195oF) chicken

385.4 ± 9.63 c

293.4 ± 14.75 f

Table VI.E.8: Total soluble protein and total dialyzable protein values for lyophilized
raw and cooked (165oF and 195oF) chicken muscle samples. Mean ± SD of total
soluble protein and total dialyzable protein in mg for total 6 pancreatin digestions (n =
6). The total amount of protein used for each pancreatin digestion is 400 mg. Different
subscripts indicates difference using One Way ANOVA test for α = 0.05 or 95%
confidence.
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Figure VI.E.8: Production of total soluble protein and total dialyzable protein because
of digestion (digested iron – non-digested iron values) by control, lyophilized raw and
cooked (165oF and 195oF) chicken muscle samples. Graphical representation of the
data from table 8. TSP: Total Soluble Protein; TDP: Total Dialyzable Protein.

Figure 8, indicates that the total soluble protein and total dialyzable protein values for
lyophilized raw and cooked (165oF and 195oF) is significantly different from each
other (p<0.05). This suggests that as the temperature of heating increases, the
digestibility of protein improves, may be because of denaturation of proteins, which
helps for better digestion. This also implies that the digestion process was adequate
and is not the component of variation responsible for production of different amount
of dialyzable and soluble iron.
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VI.F. Conclusions:

After this study, we came to following conclusions:

 Sulfhydryl and histidines are very heat labile and drops significantly after
cooking at 195oF

 The total dialyzable iron was not affected after cooking the sample at 165oF,
even though there was significant drop in sulfhydryl and histidine content.

 Dialyzable ferrous iron dropped to the level which is not significantly different
from control after heating the sample to 195oF, which is well correlated with
the drop in total sulfhydryl content.

 Chicken muscle does not need digestion to produce potentially bioavailable
forms of iron, but digestion further enhances its production.
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APPENDIX A:
STANDARD CURVE FOR PROTEIN

Obs.
No.
1

BSA (mg)

Final Abs

Abs at 542nm

0.0

I
0.053

II
0.052

0.00

2

1.0

0.107

0.104

0.052

3

2.0

0.162

0.164

0.110

4

4.0

0.268

0.268

0.216

5

6.0

0.370

0.370

0.318

6

8.0

0.475

0.474

0.422

7

10.0

0.560

0.560

0.508

Table A.1: Observations for standard protein (BSA) sample.

Std Curve for Protein
y = 0.0052x

0.6

2

R = 0.9986

Abs at 542nm

0.5
0.4
Series1

0.3

Linear (Series1)

0.2
0.1
0
0

50

100

150

mg of BSA

Fig A.1. Protein standard graph. Standard curve using bovine serum albumin as a
standard protein.
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APPENDIX B:
STANDARD CURVE FOR Fe

Abs at 562nm
II

Obs
No.

Fe Conc. (ug)

1

0.0

0.037

0.032

0.037

0.000

2

1.0

0.205

0.206

0.203

0.168

3

2.0

0.365

0.368

0.395

0.328

4

3.0

0.544

0.547

0.546

0.504

5

4.0

0.700

0.707

0.692

0.670

6

5.0

0.853

0.830

0.860

0.823

I

Final Abs.
III

Table B.1: Observations for standard iron sample.

Abs at 562nm

Std Curve for Fe
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

y = 0.166x
2

R = 0.9997
Series1
Linear (Series1)

0

1

2

3

4

5

ug/ml of Fe

Fig B.1. Iron standard graph. Standard graph for iron using a standard iron solution.
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APPENDIX C.
FLOW DIAGRAM FOR THE DIGESTION PROTOCOL

2g protein

Add DDW, adjust pH to 2.5

Add 1.4 ml of iron, adjust weight to 95g

Adjust pH to 2.0, and recheck after 15 min.

Pepsin Digestion

Incubate at 37oC in a shaking water bath

Add 5 ml of pepsin digest. Allow to digest for 2 hrs.
Keep on ice to stop digestion

Take a 20g aliquot
for titratable acidity

20g for pancreatin
digestion

Determine amount
of NaHCO3

Add dialysis tubing
having 20ml of NaHCO3

20g for pancreatin
digestion

Incubate at 370C for 30
mins, observe pH

20g for pancreatin
digestion

Pancreatin Digestion

Add 5ml of pancreatin/BILES
solution. Digest for 2 hrs.

Weigh Dialyzate

Ferrous Iron

Weigh Non-dialyzate

Total Iron

Total Iron

Ferrous Iron

Protein

Protein

Fig C.1: Flow diagram for digestion protocol.
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